STOCK TITAN

Phaos Technology estimates S$500K–S$1M funding need

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
20-F/A

Rhea-AI Filing Summary

Phaos Technology Holdings (Cayman) Limited amended its fiscal 2026 annual report to add disclosures on business-development expenses and prepayments and revise management’s internal-control conclusion. For the year ended April 30, 2026, revenue was S$132,077, down 21.2%, primarily reflecting lower orders from major customers and delays in sales orders. Net loss increased 19.9% to S$6,157,779; business-development expenses were S$1,492,610, mainly fees for mergers-and-acquisitions advisory services and introductions to business partners.

Operating cash outflow was S$10,902,972, compared with cash of S$762,234 at April 30, 2026. Management said these conditions raise substantial doubt about the company’s ability to continue as a going concern and estimates it will need S$500,000 to S$1 million of additional funding for the next 12 months. Management concluded internal controls over financial reporting were not effective, citing insufficient personnel with U.S. GAAP and SEC reporting experience and the absence of formal accounting policies and procedures; remediation measures are in progress.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

3 major · 4 points

How the balance works

Positive

  • None.

Negative

  • Major pointNet loss increased 19.9% to S$6,157,779 for the year ended April 30, 2026.
  • Major pointGoing-concern substantial doubt accompanies S$10,902,972 of operating cash outflow and S$762,234 of cash at April 30, 2026.
  • Major pointInternal controls were not effective at April 30, 2026, due to two material weaknesses.
  • Moderate pointRevenue declined 21.2% to S$132,077 for the year ended April 30, 2026.
Revenue S$132,077 Year ended April 30, 2026; down 21.2% from S$167,707 in the prior year.
Net loss S$6,157,779 Year ended April 30, 2026; increased 19.9% from S$5,137,064 in the prior year.
Net cash used in operating activities S$10,902,972 Year ended April 30, 2026.
Cash and cash equivalents S$762,234 As of April 30, 2026.
Estimated additional funding need S$500,000 to S$1 million Management estimate for the next 12 months.
Largest customer share of revenue 37.8% Year ended April 30, 2026.
Top five customers’ share of revenue 80.7% Year ended April 30, 2026.
Business-development expenses S$1,492,610 Year ended April 30, 2026; mainly mergers-and-acquisitions advisory services and introductions to business partners.
going concern financial
"substantial doubt about our ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
material weaknesses regulatory
"material weaknesses arising from insufficient personnel"
Material weaknesses are significant flaws in a company’s systems for ensuring its financial reports are accurate and reliable. Like a broken lock on a safe, they increase the chance that financial statements contain big errors or omissions, which can mislead investors about performance and risk; discovering one often raises questions about management oversight, may lead to restated results, and can affect investor confidence and a company’s valuation.
incremental borrowing rate financial
"uses its incremental borrowing rate to measure its lease liabilities"
variable interest entity financial
"PT Neura is a variable interest entity"
A variable interest entity (VIE) is a company structure where one party controls another company’s operations and economic outcomes through contracts or special arrangements instead of owning a majority of its voting shares. For investors, VIEs matter because the controlling party’s financial results, debts and risks can appear in the controller’s reports even though ownership looks separate, so understanding VIEs helps assess true exposure, governance limits and transparency—like spotting a puppet controlled by strings rather than direct ownership.
performance obligation financial
"recognize revenue when the Company satisfies the performance obligation"
A performance obligation is a specific promise in a contract to deliver a good or provide a service to a customer, and it is the unit companies use to decide when and how much revenue to record. Think of it like checklist items in a service agreement: each item completed can trigger part of the payment to be recognized as revenue. Investors care because how obligations are identified and satisfied changes the timing and amount of reported revenue and profits, affecting comparisons and valuation.
expected credit losses financial
"allowance for expected credit losses on loan receivables"
Expected credit losses are an accounting estimate of how much a lender or company expects to lose when borrowers or customers don’t fully pay what they owe, combining how likely nonpayment is with how big the loss would be. Investors care because these estimates determine how much a firm must set aside from earnings as a reserve, directly affecting reported profits, balance-sheet strength and perceptions of credit risk—like setting aside a rainy-day fund for unpaid bills.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much revenue did POAS report for fiscal 2026?

POAS reported S$132,077 in revenue for the year ended April 30, 2026, down 21.2% from S$167,707 in the prior year. The company attributed the decrease primarily to reduced orders from major customers and delayed sales orders.

What was POAS’s net loss for fiscal 2026?

POAS reported a net loss of S$6,157,779 for the year ended April 30, 2026, an increase of 19.9% from S$5,137,064 in the prior year. The company reported S$1,492,610 in business-development expenses, mainly for advisory services and introductions to business partners.

Why did POAS disclose substantial doubt about its ability to continue as a going concern?

Management cited S$10,902,972 of operating cash outflow against cash of S$762,234 at April 30, 2026. It estimates S$500,000 to S$1 million of additional funding will be needed for the next 12 months.

Why did POAS conclude its internal controls were ineffective?

Management cited insufficient U.S. GAAP and SEC reporting expertise and a lack of formal accounting policies and procedures. The company said remediation measures include recruiting qualified accounting personnel, training staff, formalizing controls, and strengthening audit committee oversight.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
true FY 0002024258 0002024258 2025-05-01 2026-04-30 0002024258 dei:BusinessContactMember 2025-05-01 2026-04-30 0002024258 us-gaap:CommonClassAMember 2026-04-30 0002024258 us-gaap:CommonClassBMember 2026-04-30 0002024258 2024-05-01 2025-04-30 0002024258 2025-04-30 0002024258 2026-04-30 0002024258 POAS:MajorShareholdersMember 2025-04-30 0002024258 POAS:MajorShareholdersMember 2026-04-30 0002024258 us-gaap:RelatedPartyMember 2025-04-30 0002024258 us-gaap:RelatedPartyMember 2026-04-30 0002024258 us-gaap:CommonClassAMember 2025-04-30 0002024258 us-gaap:CommonClassBMember 2025-04-30 0002024258 2023-05-01 2024-04-30 0002024258 us-gaap:CommonStockMember POAS:CommonClassAAndClassBMember 2023-04-30 0002024258 us-gaap:AdditionalPaidInCapitalMember 2023-04-30 0002024258 POAS:SubscriptionReceivablesMember 2023-04-30 0002024258 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-30 0002024258 us-gaap:RetainedEarningsMember 2023-04-30 0002024258 2023-04-30 0002024258 us-gaap:CommonStockMember POAS:CommonClassAAndClassBMember 2024-04-30 0002024258 us-gaap:AdditionalPaidInCapitalMember 2024-04-30 0002024258 POAS:SubscriptionReceivablesMember 2024-04-30 0002024258 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-30 0002024258 us-gaap:RetainedEarningsMember 2024-04-30 0002024258 2024-04-30 0002024258 us-gaap:CommonStockMember POAS:CommonClassAAndClassBMember 2025-04-30 0002024258 us-gaap:AdditionalPaidInCapitalMember 2025-04-30 0002024258 POAS:SubscriptionReceivablesMember 2025-04-30 0002024258 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-04-30 0002024258 us-gaap:RetainedEarningsMember 2025-04-30 0002024258 us-gaap:CommonStockMember POAS:CommonClassAAndClassBMember 2023-05-01 2024-04-30 0002024258 us-gaap:AdditionalPaidInCapitalMember 2023-05-01 2024-04-30 0002024258 POAS:SubscriptionReceivablesMember 2023-05-01 2024-04-30 0002024258 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-05-01 2024-04-30 0002024258 us-gaap:RetainedEarningsMember 2023-05-01 2024-04-30 0002024258 us-gaap:CommonStockMember POAS:CommonClassAAndClassBMember 2024-05-01 2025-04-30 0002024258 us-gaap:AdditionalPaidInCapitalMember 2024-05-01 2025-04-30 0002024258 POAS:SubscriptionReceivablesMember 2024-05-01 2025-04-30 0002024258 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-05-01 2025-04-30 0002024258 us-gaap:RetainedEarningsMember 2024-05-01 2025-04-30 0002024258 us-gaap:CommonStockMember POAS:CommonClassAAndClassBMember 2025-05-01 2026-04-30 0002024258 us-gaap:AdditionalPaidInCapitalMember 2025-05-01 2026-04-30 0002024258 POAS:SubscriptionReceivablesMember 2025-05-01 2026-04-30 0002024258 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-05-01 2026-04-30 0002024258 us-gaap:RetainedEarningsMember 2025-05-01 2026-04-30 0002024258 us-gaap:CommonStockMember POAS:CommonClassAAndClassBMember 2026-04-30 0002024258 us-gaap:AdditionalPaidInCapitalMember 2026-04-30 0002024258 POAS:SubscriptionReceivablesMember 2026-04-30 0002024258 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-04-30 0002024258 us-gaap:RetainedEarningsMember 2026-04-30 0002024258 POAS:PhaosTechnologyHoldingsCaymanLimitedMember 2025-05-01 2026-04-30 0002024258 POAS:PhaosTechnologyHoldingsCaymanLimitedMember 2026-04-30 0002024258 POAS:PhaosTechnologyHoldingsBVILimitedMember 2025-05-01 2026-04-30 0002024258 POAS:PhaosTechnologyHoldingsBVILimitedMember 2026-04-30 0002024258 POAS:PhaosTechnologyPteLtdMember 2025-05-01 2026-04-30 0002024258 POAS:PhaosTechnologyPteLtdMember 2026-04-30 0002024258 POAS:PhaosSolutionsVietnamCoLtdMember 2025-05-01 2026-04-30 0002024258 POAS:PhaosSolutionsVietnamCoLtdMember 2026-04-30 0002024258 POAS:TopFiveCustomersMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2024-05-01 2025-04-30 0002024258 POAS:TopFiveCustomersMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2025-05-01 2026-04-30 0002024258 POAS:TopFiveSuppliersMember us-gaap:SupplierConcentrationRiskMember us-gaap:SalesRevenueNetMember 2024-05-01 2025-04-30 0002024258 POAS:TopFiveSuppliersMember us-gaap:SupplierConcentrationRiskMember us-gaap:SalesRevenueNetMember 2025-05-01 2026-04-30 0002024258 POAS:CustomerAMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2024-05-01 2025-04-30 0002024258 POAS:CustomerBMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2024-05-01 2025-04-30 0002024258 POAS:CustomerCMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2024-05-01 2025-04-30 0002024258 POAS:CustomerDMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2024-05-01 2025-04-30 0002024258 POAS:CustomerEMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2024-05-01 2025-04-30 0002024258 POAS:CustomerAMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2024-05-01 2025-04-30 0002024258 POAS:CustomerDMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2024-05-01 2025-04-30 0002024258 POAS:CustomerEMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2024-05-01 2025-04-30 0002024258 POAS:CustomerAMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2025-05-01 2026-04-30 0002024258 POAS:CustomerBMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2025-05-01 2026-04-30 0002024258 POAS:CustomerCMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2025-05-01 2026-04-30 0002024258 POAS:CustomerDMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2025-05-01 2026-04-30 0002024258 POAS:CustomerEMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2025-05-01 2026-04-30 0002024258 POAS:CustomerAMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2025-05-01 2026-04-30 0002024258 POAS:CustomerDMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2025-05-01 2026-04-30 0002024258 POAS:VendorAMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember 2024-05-01 2025-04-30 0002024258 POAS:VendorBMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember 2024-05-01 2025-04-30 0002024258 POAS:VendorCMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember 2024-05-01 2025-04-30 0002024258 POAS:VendorDMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember 2024-05-01 2025-04-30 0002024258 POAS:VendorEMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember 2024-05-01 2025-04-30 0002024258 POAS:VendorAMember us-gaap:SupplierConcentrationRiskMember us-gaap:AccountsPayableMember 2024-05-01 2025-04-30 0002024258 POAS:VendorBMember us-gaap:SupplierConcentrationRiskMember us-gaap:AccountsPayableMember 2024-05-01 2025-04-30 0002024258 POAS:VendorEMember us-gaap:SupplierConcentrationRiskMember us-gaap:AccountsPayableMember 2024-05-01 2025-04-30 0002024258 POAS:VendorAMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember 2025-05-01 2026-04-30 0002024258 POAS:VendorBMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember 2025-05-01 2026-04-30 0002024258 POAS:VendorCMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember 2025-05-01 2026-04-30 0002024258 POAS:VendorDMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember 2025-05-01 2026-04-30 0002024258 POAS:VendorEMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember 2025-05-01 2026-04-30 0002024258 POAS:VendorAMember us-gaap:SupplierConcentrationRiskMember us-gaap:AccountsPayableMember 2025-05-01 2026-04-30 0002024258 POAS:VendorBMember us-gaap:SupplierConcentrationRiskMember us-gaap:AccountsPayableMember 2025-05-01 2026-04-30 0002024258 us-gaap:ComputerEquipmentMember 2026-04-30 0002024258 us-gaap:FurnitureAndFixturesMember 2026-04-30 0002024258 POAS:OfficeAndProductionEquipmentMember srt:MinimumMember 2026-04-30 0002024258 POAS:OfficeAndProductionEquipmentMember srt:MaximumMember 2026-04-30 0002024258 POAS:RenovationMember 2026-04-30 0002024258 2024-01-19 2024-01-19 0002024258 2025-08-31 2025-09-30 0002024258 POAS:LoanAgreementMember 2026-03-04 0002024258 POAS:ProductionEquipmentMember 2025-04-30 0002024258 POAS:ProductionEquipmentMember 2026-04-30 0002024258 POAS:ComputerAndSoftwareMember 2025-04-30 0002024258 POAS:ComputerAndSoftwareMember 2026-04-30 0002024258 us-gaap:FurnitureAndFixturesMember 2025-04-30 0002024258 us-gaap:OfficeEquipmentMember 2025-04-30 0002024258 us-gaap:OfficeEquipmentMember 2026-04-30 0002024258 POAS:RenovationMember 2025-04-30 0002024258 us-gaap:ConstructionInProgressMember 2025-04-30 0002024258 us-gaap:ConstructionInProgressMember 2026-04-30 0002024258 POAS:OfficePremiseMember 2026-04-30 0002024258 2022-08-11 2022-08-11 0002024258 2022-08-11 0002024258 2022-11-01 2022-11-01 0002024258 2022-11-01 0002024258 us-gaap:CommonClassAMember 2024-04-30 0002024258 us-gaap:CommonClassBMember 2024-04-30 0002024258 us-gaap:InvestorMember 2023-05-01 2024-04-30 0002024258 us-gaap:MeasurementInputSharePriceMember 2026-04-30 0002024258 us-gaap:MeasurementInputExercisePriceMember 2026-04-30 0002024258 us-gaap:MeasurementInputPriceVolatilityMember 2026-04-30 0002024258 us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-04-30 0002024258 us-gaap:MeasurementInputExpectedTermMember 2026-04-30 0002024258 us-gaap:MeasurementInputExpectedDividendRateMember 2026-04-30 0002024258 POAS:TonghuaiSGEnterprisePteLtdMember 2024-05-01 2025-04-30 0002024258 POAS:TonghuaiSGEnterprisePteLtdMember 2025-05-01 2026-04-30 0002024258 POAS:SinglightTechnologyHoldingsPteLtdMember 2024-05-01 2025-04-30 0002024258 POAS:SinglightTechnologyHoldingsPteLtdMember 2025-05-01 2026-04-30 0002024258 POAS:TonghuaiSGEnterprisePteLtdMember 2025-04-30 0002024258 POAS:TonghuaiSGEnterprisePteLtdMember 2026-04-30 0002024258 POAS:TonghuaiSGEnterprisePteLtdMember POAS:MajorShareholderMember 2025-05-01 2026-04-30 0002024258 us-gaap:InlandRevenueSingaporeIRASMember 2025-05-01 2026-04-30 0002024258 us-gaap:InlandRevenueSingaporeIRASMember srt:MaximumMember 2025-05-01 2026-04-30 0002024258 srt:MinimumMember us-gaap:InlandRevenueSingaporeIRASMember 2025-05-01 2026-04-30 0002024258 POAS:InlandRevenueVietnamMember srt:MaximumMember 2025-05-01 2026-04-30 0002024258 POAS:InlandRevenueVietnamMember srt:MinimumMember 2025-05-01 2026-04-30 0002024258 POAS:InlandRevenueVietnamMember 2025-05-01 2026-04-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:SGD iso4217:SGD xbrli:shares POAS:Segment iso4217:VND

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 20-F/A

 

(Mark One)

☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(B) OR 12(G) OF THE SECURITIES EXCHANGE ACT OF 1934

 

OR

 

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended April 30, 2026

 

OR

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

OR

 

☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from to

 

Commission file number: 001-42952

 

Phaos Technology Holdings (Cayman) Limited

(Exact name of Registrant as specified in its charter)

 

Cayman Islands

(Jurisdiction of incorporation or organization)

 

55 Ayer Rajah Crescent,

#5-05

Singapore 139949

(Address of principal executive offices)

 

Gan Hong Loon

hongloon@phaostech.com

+65 6250 3877

55 Ayer Rajah Crescent,
#05-05 Singapore 139949
(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)

 

Securities registered or to be registered pursuant to Section 12(b) of the Act:

 

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A Ordinary shares, par value $0.0001 per Class A Ordinary Share   POAS   NYSE American

 

Securities registered or to be registered pursuant to Section 12(g) of the Act: None

 

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None

 

Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report: 16,446,750 Class A Ordinary Shares and 15,125,251 Class B Ordinary Shares issued and outstanding as of April 30, 2026.  

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

 

☐ Yes ☒ No

 

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

 

☐ Yes ☒ No

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

☒ Yes ☐ No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

 

☒ Yes ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Non-accelerated filer ☒
Accelerated filer ☐ Emerging growth company ☒

 

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:

 

U.S. GAAP ☒ International Financial Reporting Standards as issued Other ☐
  by the International Accounting Standards Board ☐  

 

If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.

 

☐ Item 17 ☐ Item 18

 

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Securities Exchange Act of 1934).

 

☐ Yes ☒ No

 

(APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)

 

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.

 

☐ Yes ☐ No

 

 

 

 
 

 

Table of Contents

 

    Page
PART I  
Item 5. Operating and Financial Review and Prospects 2
PART II  
Item 15. Controls and Procedures 16
PART III  
Item 17. Financial Statements 17
Item 18. Financial Statements 17
Item 19. Exhibits 17

 

i
 

 

EXPLANATORY NOTE

 

This Amendment No. 1 on Form 20-F/A (the “Form 20-F/A”) amends the annual report on Form 20-F of Phaos Technology Holdings (Cayman) Limited (the “Company,” “we” or “our”) for the fiscal year ended April 30, 2026, originally filed with the U.S. Securities and Exchange Commission (“SEC”) on August 31, 2026 (the “Form 20-F”). This Form 20-F/A is being filed in response to the comment letter dated October 29, 2026 (the “SEC Comment Letter”) from the staff of the SEC and relates to matters discussed in the SEC Comment Letter. Item 5. Operating and Financial Review and Prospects, of Part I in the Form 20-F is amended by this Form 20-F/A to include additional disclosures regarding the business development expenses and the prepayments. Item 15. Controls and Procedures of Part II in the Form 20-F is amended by this Form 20-F/A to include the revised conclusion in Management’s Annual Report on Internal Control over Financial Reporting. Item 18. Financial Statements, of Part III in the Form 20-F is amended by this Form 20-F/A to include additional disclosures regarding the prepayments. Item 19. Exhibits, of Part III in the Form 20-F is amended by this Form 20-F/A to include the consent of the Company’s independent registered public accounting firm and new certifications of the Company’s principal executive officer and principal financial officer, as revised in response to the SEC comments.

 

This Amendment on Form 20-F/A speaks as of the filing date of the Form 20-F on August 31, 2026. Other than as set forth herein, the Form 20-F/A does not, and does not purport to, amend, update or restate any other information or disclosure included in the Form 20-F or reflect any events that have occurred since August 31, 2026.

 

1

 

 

Item 5. Operating and Financial Review and Prospects

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and related notes included elsewhere in this form 20-F. This discussion and analysis and other parts of this annual report on Form 20-F contains forward-looking statements based upon current beliefs, plans and expectations that involve risks, uncertainties and assumptions. Our actual results and the timing of selected events could differ materially from those anticipated in these forward-looking statements as a result of several factors, including those set forth under “Risk Factors” and elsewhere in this form 20-F. You should carefully read the “Risk Factors” section of this form 20-F. to gain an understanding of the important factors that could cause actual results to differ materially from our forward-looking statements. 

 

5.A. Operating Results.

 

Overview

 

Phaos Technology Holdings (Cayman) Limited (the “Company”) is an investment holding company incorporated on March 7, 2024 under the laws of the Cayman Islands. The Company through its subsidiary assembling and commercialization of such advanced microscopy-related solutions, technologies and products. Using its patented microsphere-assisted technology, the Company can significantly increase the magnification of existing traditional optical microscope by up to 4 times compared to its competitors, hence allowing clients to see beyond the optical limit in an effective manner. Currently, it is the only commercially available advanced optical microscope that can see below the 200nm optical limit, within a commercially viable working distance.

 

Our business is primarily involved on the assembling and commercialization of advanced microscopy-related solutions, technologies and products tailored for precision measurement and magnification purposes. Our product range includes microscopy solutions, featuring:

 

  i) Super-resolution imagers capable of achieving imaging down to 137 nm;
  ii) Specialized microscopes designed to meet the diverse needs of various industries; and
  iii) Three-dimensional (3-D) real-time image magnifiers for enhanced visualization.

 

Traditional optical microscopes are able to see up to 220 nm, while our solution allows users to see up to 137 nm. As a result, we believe that this is considered by the optical industry as a super resolution optical microscopy solution.

 

In addition to our hardware offerings, we provide complementary proprietary software developed entirely in-house to complement our microscopy solutions. Our software includes AI components that utilize computer vision and machine learning algorithms to support image-based defect detection, recognition pattern analysis, research applications, and quality assurance and quality control (“QA/QC”) functions. Our AI-assisted solutions are trained using customer-supplied inspection data and are customized for each customer’s products, inspection standards and operational requirements. See “Business - Overview” for additional information.

 

For the years ended April 30, 2025 and 2026, the provision of microscopy products and components contributed to 95.9% and 91.8% of our revenue, respectively.

 

We distribute our microscopy products and software solutions through a combination of distributors and direct customer sales channels, primarily in Singapore and Indonesia, while continuing to expand across Southeast Asia and South Asia. In recent periods, we have implemented a sales channel diversification strategy focused on increasing direct engagement with end customers in order to strengthen brand recognition, diversify our customer base and reduce reliance on sales to distributors.

 

Our microscopy solutions accommodate a diverse range of applications enabling us to serve a wide range of customer needs and capitalize on emerging growth opportunities in the region. Our diverse customer base primarily includes industries with usage in fields such as manufacturing, research & development, biomedical, semiconductors, Printed Circuit Board (“PCB”), electronics, precision engineering, injection molding, research, healthcare, QA/QC and diagnostics. Our business strategic focus involves strengthening our market position in Singapore and Indonesia, and progressively expanding into the Southeast Asian region.

 

Revenue for the year ended April 30, 2026 was S$132,077, compared to S$167,707 for the year ended April 30, 2025. The decline in revenue was primarily attributable to delayed sales orders from our customers. During the same period, revenue concentration from our largest single customer increased from approximately 23% of total revenue to approximately 38%, while the contribution from our five largest customers decreased from approximately 85% to approximately 81% of total revenue.

 

Additional resources have been allocated to support our regional expansion strategy in Singapore and Malaysia in response to the reduction in sales orders from certain of our largest customers. Singapore remains our primary operating market, where we continue to strengthen commercial relationships and expand our customer base across the manufacturing, semiconductor, precision engineering, biomedical and research sectors. Malaysia represents our principal near-term expansion market, where we are establishing direct customer relationships and increasing our market presence across similar industry verticals. We continue to implement our direct sales strategy through direct engagement with end customers, led by our Managing Director, Mr. Tay Beng Boon, who works closely with customers to develop tailored solutions designed to address their operational requirements. To support these initiatives, we have allocated up to US$2.0 million toward direct sales and marketing activities, product demonstrations, participation in industry trade shows and conferences, and enhancement of after-sales service capabilities in Singapore and Malaysia. We expect that our ongoing customer diversification and regional expansion efforts will allow us to increase and stabilize product sales over time through a broader customer base and reduced customer concentration.

 

In June 2025, the Company reduced its workforce from 25 to 10 full-time employees to align its cost structure with current operational needs following the decline in revenue for the year ended April 30, 2025. As a result of the workforce reduction and other cost management measures, the Company’s monthly operating expenses have been reduced to below S$200,000. Management believes that the workforce reduction has not adversely affected the Company’s ability to support its existing operations, attract or retain personnel, or continue implementing its direct sales strategy.

 

We believe our customer diversification and cost management initiatives have begun to produce initial operational improvements. For the year ended April 30, 2025, our revenue was S$167,707 (US$131,667), and our net loss and accumulated deficit were S$5,137,064 (US$4,033,109) and S$12,167,130 (US$9,552,412), respectively. For the year ended April 30, 2026, our revenue was S$132,077 (US$103,694) and our net loss and accumulated deficit were S$6,157,779 (US$4,834,474) and S$18,324,909 (US$14,386,886). Business operations in Singapore contributed approximately 86.0% of our Group’s revenue for the year ended April 30, 2026. We believe these results reflect the initial impact of our efforts to broaden our customer base, reduce customer concentration and improve operational efficiency.

 

In addition, service revenue increased as a result of maintenance-based contracts for our customers. As we grow our product and software range, we expect that service revenue will continue to contribute a greater percentage of our revenue going forward.

 

2

 

 

Key Factors Affecting the Results of Our Group’s Operations

 

Our operating results are primarily affected by those factors set out in the below sections:

 

Supply chain interruptions

 

Supply chain interruptions pose significant challenges to businesses, impacting operations, production, and ultimately, the ability to meet customer demand. We conduct a comprehensive analysis of the supply chain to identify potential vulnerabilities and points of failure. This includes assessing dependencies on critical suppliers, geographical risks, transportation logistics, and regulatory compliance issues. The Group will strengthen relationships with key suppliers through open communication, collaboration, and regular performance evaluations. We develop robust contingency plans to address potential supply chain disruptions, including natural disasters, geopolitical events, trade disputes, and pandemics. These plans include clear protocols and procedures for activating contingency measures swiftly and effectively when disruptions occur. By proactively addressing supply chain interruptions and implementing risk management strategies, businesses can enhance our resilience and mitigate the impact of disruptions on operations and customer satisfaction.

 

Fluctuations in material prices and quantities

 

Fluctuations in material prices and quantities can significantly affect the cost of assembling microscopy products. To mitigate these impacts, we implement effective inventory management practices, optimizing levels based on demand forecasts and lead times. Maintaining adequate buffer stocks helps offset sudden price increases or supply shortages. Additionally, we continuously assess cost reduction strategies such as process optimization and exploring alternative materials or components with similar performance at lower costs. These measures not only reduce overall production costs but also enhance our resilience to price fluctuations. By implementing these strategies, we can better manage our susceptibility to market volatility, strengthening our competitiveness and ensuring sustained performance in the market.

 

Pricing and profitability

 

Setting the right pricing strategy for our microscopy products is crucial for generating revenue and achieving profitability. We provide the software as a complementary product to our microscopy products. Other factors such as market demand, tight competition, product differentiation, and perceived value all influence our pricing decisions. Balancing affordability with profitability is essential to attract customers while maximizing our returns. We distribute through a combination of distributors and direct customer sales channels, primarily in Singapore and Indonesia, while continuing to expand across Southeast Asia and South Asia. In recent periods, we have implemented a sales channel diversification strategy focused on increasing direct engagement with end customers in order to strengthen brand recognition, diversify our customer base and reduce reliance on sales to distributors and while it provides broader direct customer base, we are currently uncertain as to whether it may or may not result in lower margins due to many other external macro-factors in play such as competitors, innovation within the optical industry as well as the general economic environment.

 

Compliance with health, and safety regulations

 

Compliance with health and safety regulations is paramount to our business operations, as non-compliance can lead to penalties and reputational damage. We closely monitor existing regulations and proactively adapt our practices to ensure compliance. Additionally, we stay vigilant regarding new and evolving laws and regulations that may impact our operations. To mitigate the risks associated with regulatory changes, we maintain robust internal controls and processes focused on compliance with health and safety regulations. This includes conducting regular audits, implementing training programs for employees, and engaging with regulatory authorities to stay informed about emerging requirements. By prioritizing compliance with health and safety regulations and staying abreast of regulatory developments, we aim to safeguard our business against potential penalties and reputational harm while fostering a safe and sustainable operating environment.

 

Inflation

 

Inflation can drive the prices of raw materials and components used in our microscopy products upwards. This increase in material costs can be attributed to various factors, including supply chain disruptions, and fluctuations in commodities prices. Energy prices, particularly crude oil prices, can impact transportation and production costs as well. Overall, we may face higher procurement costs for essential components and materials as well as elevated expenses for transportation, energy and labor. To mitigate the effects of inflation on material costs and profit margins, we will continuously assess cost reduction strategies, including exploring alternative sources of materials.

 

3

 

 

Results of Operations

 

Comparison of Years Ended April 30, 2026 and 2025

 

The following table summarizes the consolidated results of our operations for the year ended April 30, 2026 and 2025, respectively:

 

    For Years Ended April 30,  
    2026     2025     Variance        
    SGD     USD     SGD     USD     SGD     USD     % Change  
Revenue     132,077       103,694       167,707       131,667       (35,630 )     (27,973 )     -21.2 %
Costs of products sold     (114,767 )     (90,104 )     (130,641 )     (102,566 )     15,874       12,462       -12.2 %
                                                         
Employee benefits expense     (2,739,571 )     (2,150,836 )     (2,462,326 )     (1,933,172 )     (277,245 )     (217,664 )     11.3 %
Research and Development expenses     -       -       (139,720 )     (109,694 )     139,720       109,694       -100.0 %
Depreciation expenses     (160,846 )     (126,281 )     (186,963 )     (146,785 )     26,117       20,504       -14.0 %
Operating lease expenses     (119,823 )     (94,074 )     (142,670 )     (112,010 )     22,847       17,936       -16.0 %
Other operating expenses     (3,319,747 )     (2,606,334 )     (1,161,663 )     (912,022 )     (2,158,084 )     (1,694,312 )     185.8 %
(Allowance for)/Reversal of allowance for expected credit losses on loan receivables     106,116       83,312       (1,223,608 )     (960,655 )     1,329,724       1,043,967       -108.7 %
Loss from operations     (6,216,561 )     (4,880,623 )     (5,279,884 )     (4,145,237 )     (936,677 )     (735,386 )     17.7 %
                                                         
Non-operating income:                                                        
Other income     67,949       53,347       151,283       118,772       (83,334 )     (65,425 )     -55.1 %
Interest expense     (9,167 )     (7,198 )     (8,463 )     (6,644 )     (704 )     (554 )     8.3 %
Total non-operating income, net     58,782       46,149       142,820       112,128       (84,038 )     (65,979 )     -58.8 %
                                              -          
Loss before income tax expense     (6,157,779 )     (4,834,474 )     (5,137,064 )     (4,033,109 )     (1,020,715 )     (801,365 )     19.9 %
Income tax expense     -       -       -       -       -       -       -  
Net loss     (6,157,779 )     (4,834,474 )     (5,137,064 )     (4,033,109 )     (1,020,715 )     (801,365 )     19.9 %
                                                         
Other comprehensive income:                                                        
Foreign currency translation adjustment, net of income tax     89,837       70,531       (1,143 )     (897 )     90,980       71,428       -7959.8 %
Total comprehensive   loss     (6,067,942 )     (4,763,943 )     (5,138,207 )     (4,034,006 )     (929,735 )     (729,937 )     18.1 %
                                              -          
Basic and diluted loss per  share to ordinary shareholders     (0.49 )     (0.38 )     (0.49 )     (0.38 )     0.00       0.00       0.0 %

  

4

 

 

Revenue

 

We provide services through sales of microscopes and parts. The following table provides financial information for each of these operating groups:

 

   For Years Ended April 30, 
   2026   2025   Variance     
   SGD   USD   SGD   USD   SGD   USD   % Change 
Revenue:                                   
Sales of microscopes and parts   121,232    95,180    160,899    126,322    (39,667)   (31,142)   -24.7%
Services   10,845    8,514    6,808    5,345    4,037    3,169    59.3%
Total   132,077    103,694    167,707    131,667    (35,630)   (27,973)   -21.2%
                                    
Revenue as a percentage of total:                                   
Sales of microscopes and parts   91.8%   91.8%   95.9%   95.9%            
Services   8.2%   8.2%   4.1%   4.1%            
Total   100.0%   100.0%   100.0%   100.0%            

 

The principal activities of the Company for the years ended April 30, 2026 and 2025 was sales of microscopy solutions, products and accessories. Our revenue for the years ended April 30, 2026 and 2025 was S$132,077 (approximately US$103,694) and S$167,707 (approximately US$131,667), respectively, representing a decrease of 21.2%. This reduction in revenue was primarily attributed to a reduction in sales orders from our largest customers, with the price of the products remaining largely unchanged. In order to further build brand recognition and to diversify customer base, the Group has embarked on a diversification strategy whereby the Group targets much more customers.

 

For the year ending April 30, 2026 and April 30, 2025, the largest customer is neither related to the Company nor to the shareholders of the Company. In addition, we have zero returns for our products for the years ended April 30, 2026 and 2025.

 

5

 

 

Other Income

 

The following table provides financial information for the different types of Other Income:

 

   Years Ended April 30, 
   2026   2025   Variance 
   SGD   USD   SGD   USD   SGD   USD   % Change 
                             
Interest income   225    177    5,832    4,579    (5,607)   (4,402)   (96.1)%
Government Grants   20,968    16,462    62,644    49,182    (41,676)   (32,720)   (66.5)%
Other   46,756    36,708    82,807    65,011    (36,051)   (28,303)   (43.5)%
Total   67,949    53,347    151,283    118,772    (83,334)   (65,425)   (55.1)%

 

For the year ended April 30, 2025 to April 30, 2026, there was a decrease of S$83,334 (approximately US$65,425) or 55.1% from S$151,283 (approximately US$118,772) to S$67,949 (approximately US$53,347), This was primarily attributable to a decrease in government grants of S$41,676 (approximately US$32,720) or 66.5% from S$62,644 (approximately US$49,182) for the year ended April 30, 2025 to S$20,968 (approximately US$16,462) for the year ended April 30, 2026. We expect the decrease in government grants to continue as the Company matures.

 

Cost of sales

 

    For Years Ended April 30,  
    2026     2025     Variance        
    SGD     USD     SGD     USD     SGD     USD     % Change  
                                           
Tools and hardware and Production Labor     108,117       84,883       122,836       96,439       (14,719 )     (11,556 )     (12.0 )%
Inward freight     6,650       5,221       7,805       6,127       (1,155 )     (906 )     (14.8 )%
Total     114,767       90,104       130,641       102,566       (15,874 )     (12,462 )     (12.2 )%

 

Our cost of services comprises mainly tools and hardware, production labor and inward freight. Our total cost of sales decreased by S$15,874 (approximately US$12,462) or by 12.2% from S$130,641 (approximately US$102,566) for the year ended April 30, 2025, to S$114,767 (approximately US$90,104) for the year ended April 30, 2026. This was primarily attributable to a decrease of 12.0% in our purchase from S$122,836 (approximately US$96,439) for the year ended April 30, 2025 to S$108,117 (approximately US$84,883) for the year ended April 30, 2026. Such a decrease was in line with our decreased revenue due to diversification of customer base and delayed of sales orders from customers.

 

Payroll

 

As of April 30, 2025, and 2026 we have 25 and 10 full time employees. We enter into employment contracts with our full-time employees, which are not covered by collective bargaining agreements. The remuneration to our employees includes fixed salaries, performance-based bonuses, allowances and sales commissions for employees. We determine employees’ remuneration based on a number of factors including years of experience, qualifications and market rates.

 

Operating lease expenses

 

As of April 30, 2025, the Company has four office premise lease agreements with lease terms ranging from two to three years, and has paid a sum of S$142,670 (approximately US$112,010) for the expenses. As of April 30, 2026, the Company has two office premise lease agreements with lease terms of three years, and has paid a sum of S$119,823 (approximately US$94,074) for the expenses. The company has a non-cancellable lease for an office premise located at The Curie Singapore Science Park Unit #02-01, Singapore 118258 with a lease term of 3 years and a non-cancellable lease for an office premise located at 55 Ayer Rajah Crescent #05-05 Singapore 139949 with a lease term of 3 years. As of April 30, 2025, the company entered to a lease agreement for office premises at Shophouse SH01-01, Binh Minh Garden Project, Duc Giang Ward, Long Bien District, Hanoi City, Vietnam with a lease term of 2 years, this lease has been terminated as at April 30, 2026.

 

6

 

 

General and administrative expenses

 

   For Years Ended April 30, 
   2026   2025   Variance     
   SGD   USD   SGD   USD   SGD   USD   % Change 
                             
Advertising fee and marketing cost   3,688    2,895    10,335    8,114    (6,647)   (5,219)   -64.3%
Consultancy fee   640,743    503,047    55,422    43,512    585,321    459,535    1056.1%
Professional and legal fees   158,329    124,304    33,968    26,669    124,361    97,635    366.1%
Travelling expenses   71,699    56,291    165,435    129,883    (93,736)   (73,592)   -56.7%
Staff training   2,634    2,068    18,185    14,277    (15,551)   (12,209)   -85.5%
Other expenses   2,442,654    1,917,729    878,318    689,567    1,564,336    1,228,162    178.1%
Total   3,319,747    2,606,334    1,161,663    912,022    2,158,084    1,694,312    185.8%

 

For the year ended April 30, 2025 and 2026, other operating expenses consist primarily of advertising fee and marketing cost, consultancy fee, professional and legal fees, travelling expenses, staff training and other expenses.

 

Operating expenses increased by S$2,158,084 (approximately US$1,694,312), or 185.8% from S$1,161,663 (approximately US$912,022) for the year ended April 30, 2025 to S$3,319,747 (approximately US$2,606,334) for the year ended April 30, 2026. The increase was primarily due to consultancy fees and other expenses, mainly from IPO expenses S$79,425 (approximately US$62,357) and business development expenses S$1,492,610 (approximately US$1,171,848).

 

Business development expenses of S$1,492,610 incurred for the year ended April 30, 2026 comprised of fees for mergers and acquisitions advisory services and introductions to business partners as we continue to expand our businesses. These fees were a primary contributor to the increase in General and Administrative expenses and net loss from the year ended April 30, 2025 to April 30, 2026, a 100% increase contributing to 45.0% of the General and Administrative expenses. This indicates the company sought to promote its products and services more aggressively in the market regionally, reflecting heightened administrative and operational activities as well as increased expansion initiatives undertaken by the company.

 

Finance expenses

 

Our finance expenses increased by S$704 (approximately US$554) from S$8,463 (approximately US$6,644) for the year ended April 30, 2025 to S$9,167 (approximately US$7,198) for the year ended April 30, 2026.

 

Research and development expenses

 

The following table sets forth a breakdown of our research and development expenses for the years indicated:

 

   As of April 30, 
   2026   2025   Variance     
   SGD   USD   SGD   USD   SGD   USD   % Change 
                             
Research and Development Expenses   -    -    139,720    109,694    139,720    109,694    (100.0)%
Total Research and Development Expenses   -    -    139,720    109,694    139,720    109,694    (100.0)%

 

Research and development expenses primarily consisted of testing and retrieval of relevant test reports. Research and development expenses decreased by approximately 100.0%, from S$139,720 (US$109,964) for the year ended April 30, 2025 to nil for the year ended April 30, 2026. The decrease is due to a shift from solely sales via distributors to combination of sales via distributors and direct customers.

 

7

 

 

Impairment of loan receivables

 

During the year ended April 30, 2026, impairment of loan to third party was reversed by S$106,116 (US$83,312), after repayment was higher than the carrying amount of S$400,000 (US$314,040) as at April 30, 2025.

 

5.B. Liquidity and Capital Resources.

 

Our primary source of liquidity has been cash generated from our business operations, proceeds from equity and debt financing, and loans from our major shareholder, TongHuai SG Enterprise Pte. Ltd. Historically, these sources have been sufficient to meet our working capital and capital expenditure requirements. However, as discussed below, there is substantial doubt about our ability to continue as a going concern.

 

As of the year ending April 30, 2026, the Group had a net loss of S$6,157,779 (approximately US$4,834,474) and incurred a negative cashflow from operations of S$10,902,972 (approximately US$8,559,924), against a cash balance of S$762,234 (approximately US$598,430). This raises substantial doubt about our ability as a going concern.

 

To sustain our ability to support our ongoing activities, we considered supplementing our sources of funding through the following:

 

  - Cash flow from operations through sale of our products
  - Continuous support from major shareholders, such as TongHuai SG Enterprise Pte. Ltd. which has provided for the shareholders’ loan

 

8

 

 

Management has commenced a strategy to raise debt and equity. However, there can be no certainty that these additional financings will be available on acceptable terms or at all. If management is unable to execute this plan, there will likely be a material adverse effect on the Company’s business. All these factors raise substantial doubt about the ability of the Company to continue as a going concern.

 

Short-Term Liquidity (Next 12 Months)

 

Based on our current monthly cash burn rate of less than S$200,000 per month following our June 2025 restructuring, we estimate that we will require approximately S$500,000 to S$1 million in additional funding to satisfy our cash requirements for the next 12 months. Our primary uses of cash during this period are expected to include: (i) operating expenses, including employee compensation, rent, and professional services; (ii) sales and marketing initiatives to expand our customer base; and (iii) repayment of our bank loan obligations, which mature in July 2027. As of April 30, 2026, we had S$78,366 (US$61,526) outstanding for our temporary bridging loan, which bears interest at 4.75% per annum.

 

Long-Term Liquidity (Beyond 12 Months)

 

Our long-term liquidity needs will depend on numerous factors, including: (i) our ability to achieve profitability and generate positive cash flows from operations; (ii) the rate at which we expand our operations and customer base in Singapore and the Southeast Asian region; (iii) our capital expenditure requirements for equipment and technology; and (iv) our ability to access debt or equity financing on acceptable terms. We currently do not have any committed sources of long-term financing and will need to raise additional capital to support our growth strategy and repay our outstanding indebtedness. There can be no assurance that such financing will be available on favorable terms, or at all.

 

There is no immediate liquidation concern for the Company; however, there is substantial doubt on the Company being a going concern but the management has positive mitigation plan to handle going concern issue.

 

Capital Raising Strategy

 

To address our liquidity needs and the substantial doubt about our ability to continue as a going concern, we are pursuing a capital raising strategy that may include: (i) additional equity financing, including potential follow-on public offerings or private placements; (ii) debt financing, including bank loans or convertible instruments; and (iii) continued support from our major shareholder, TongHuai SG Enterprise Pte. Ltd., where S$2,995,423 (US$2,351,707) as at April 30, 2025 has been fully repaid as at April 30, 2026. These loans from TongHuai SG Enterprise Pte. Ltd. are interest-free, unsecured, and due on demand. There is no written agreement or commitment obligating TongHuai SG Enterprise Pte. Ltd. to provide additional funding, although the shareholder has historically supported the Company’s operations and has indicated its intention to continue doing so. Management is actively evaluating financing alternatives; however, as of the date of this report, no definitive financing agreements have been entered into and there can be no assurance that any such financing will be obtained.

 

Impact of November 2025 IPO

 

On November 12, 2025, we completed our initial public offering of 2,700,000 Class A ordinary shares at a public offering price of $4.00 per share, and on November 24, 2025, the underwriters exercised their over-allotment option in full to purchase an additional 405,000 Class A ordinary shares. After deducting underwriting discounts and commissions of 7.5% ($0.30 per share) and estimated offering expenses of approximately US$1,598,023, we received net proceeds of approximately US$10,871,976. These proceeds are being used for working capital and general corporate purposes, including expansion through acquisitions. While the IPO proceeds provide additional liquidity, the Company continues to evaluate its ongoing funding requirements and may need to raise additional capital to support its operations and growth strategy.

 

9

 

 

The audited consolidated financial statements do not include any adjustments that might be necessary if the Group is unable to continue as a going concern.

 

   For Years Ended April 30, 
   2026   2025   Variance     
   SGD   USD   SGD   USD   SGD   USD   % Change 
                             
Liquidity and capital resources:                                   
Cash and cash equivalents at the beginning of the year   129,552    101,712    2,312,107    1,815,235    (2,182,555)   (1,713,523)   -94.4%
                                    
Net cash used in operating activities   (10,902,972)   (8,559,924)   (3,653,376)   (2,868,265)   (7,249,596)   (5,691,659)   198.4%
Net cash used in investing activities   468,397    367,739    (332,838)   (261,311)   801,235    629,050    -240.7%
Net cash generated from financing activities   10,977,420    8,618,372    1,804,802    1,416,950    9,172,618    7,201,422    508.2%
                                    
Translation loss   89,837    70,531    (1,143)   (897)   90,980    71,428    -7959.8%
                                    
Net increase/(decrease) in cash and cash equivalents   632,682    496,718    (2,182,555)   (1,713,523)   2,815,237    2,210,241    -129.0%
                                    
Cash and cash equivalents as at the end of the year   762,234    598,430    129,552    101,712    632,682    496,718    488.4%

 

On August 11, 2022, the Company has acquired a 5-year S$270,000 temporary bridging loan which expires in July 2027. The bank loan which carries interest of 4.75% per annum is secured by joint and several guarantee by Andrew Yeo Eng Sian (former Chief Executive Officer) and Beh Hook Seng (Executive Chairman). As of April 30, 2026, the carrying amount of the bank loan was S$78,366 (US$61,526).

 

On November 1, 2022, the Company has acquired another 5-year S$500,000 secured fixed rate bank loan which expires in November 2027. The bank loan which carries interest of 7.75% per annum is secured by joint and several guarantee by Beh Hook Seng, Andrew Yeo Eng Sian, Wong Teck Far and Chua Jun Hao, David. As of April 30, 2025, the bank loan has been fully paid.

 

Cash Flows used in Operating Activities

 

For the year ended April 30, 2026, net cash flow used in operating activities was S$10,902,972 (approximately US$8,559,924) compared to cash flow used in operations of S$3,653,376 (approximately US$2,868,265) for the year ended April 30, 2025. The increase in cash flow used in operations was primarily the result of higher net loss and increase in prepayments.

 

For the year ended April 30, 2025, net loss of S$5,137,064 (approximately US$4,033,109) adjusted for non-cash items which included depreciation S$186,963 (approximately US$146,785). This was offset against net cash outflow arising from the net change in operating assets and liabilities of S$69,553 (approximately US$54,606).

 

Cash Flows used in Investing Activities

 

Net cash from investing activities was S$468,397 (approximately US$367,739) for the year ended April 30, 2026, as compared to net cash used of S$332,838 (approximately US$261,311) for the year ended April, 2025.

 

10

 

 

Net cash from investing activities for the year ended April 30, 2026 consisted of repayment of loan to third-party, purchase of production equipment, computer and software, furniture and fittings, office equipment and renovation in the amount of S$468,397 (approximately US$367,739). On January 19, 2024, Phaos Technology Pte. Ltd. (the “Lender”) entered into a loan agreement with PT Neura Integrasi Solusi (the “Borrower”) for the purposes of further business activities in Indonesia and working capital, this loan has been fully written off as at April 30, 2026.

 

Net cash used in investing activities for the year ended April 30, 2025 consisted of a loan to third-party, purchase of production equipment, computer and software, furniture and fittings, office equipment and renovation in the amount of S$332,838 (approximately US$261,311).

 

Cash Flows from Financing Activities

 

Net cash generated from financing activities was S$10,977,420 (approximately US$8,618,372) for the year ended April 30, 2026, as compared to S$1,804,802 (approximately US$1,416,950) for the year ended April 30, 2025.

 

Net cash generated from financing activities for the year ended April 30, 2026 consisted of net proceeds from related party, TongHuai SG Enterprise Pte. Ltd., of S$760,000 (approximately US$596,676), and offset by repayments of borrowings of S$55,613 (approximately US$43,662) and repayment to major shareholder of S$3,755,423 (approximately US$2,948,383).

 

Net cash generated from financing activities for the year ended April 30, 2025 consisted of proceeds from subscription monies in the amount of S$255,195 (approximately US$200,354), net proceeds from related party, TongHuai SG Enterprise Pte. Ltd., of S$2,262,670 (approximately US$1,776,422), and offset by repayments of borrowings of S$440,455 (approximately US$345,801) and deferred offering costs of S$272,608 (approximately US$214,025).

 

Working Capital

 

As of the year ending April 30, 2026, the Group’s incurred a negative cashflow from operations of S$10,902,972 (approximately US$8,559,924), against a cash balance of S$762,234 (approximately US$598,430).

 

For the year ended April 30, 2025, the Group’s incurred a negative cashflow from operations of S$3,653,376 (approximately US$2,868,265), against a cash balance of S$129,552 (approximately US$101,712).

 

Discussion of Certain Balance Sheet Items

 

The following table set forth selected information from our consolidated balance sheets as of April 30, 2026 and April 30, 2025. This information should be read together with our consolidated financial statements and related notes included elsewhere in this 20-F.

 

Account payables

 

  As of April 30, 
   2026   2025   Variance     
   SGD   USD   SGD   USD   SGD   USD   % Change 
                                    
Account payables   298,826    234,608    93,931    73,745    204,895   160,863   218.1%

 

Account payables increased by S$204,895 (approximately US$160,863) from S$93,931 (approximately US$73,745) to S$298,826 (approximately US$234,608) as of April 30, 2025, to April 30, 2026, respectively. The turnover days is 625 days as of April 30, 2026 and 542 days as of April 30, 2025. We remain focused on managing our accounts payable efficiently to support our financial stability and growth objectives in the future.

 

11

 

 

Account receivables

 

   For Years Ended April 30, 
   2026   2025   Variance     
   SGD   USD   SGD   USD   SGD   USD   % Change 
                             
Account receivables, before allowance for expected credit losses   1,751    1,375    38,384    30,135    (36,633)   (28,760)   -95.4%
Accounts Receivables   1,540    1,209    38,275    30,050    (36,735)   (28,841)   -96.0%
(1 - 90 days)                                   
Accounts Receivables   211    166    -    -    211    166    N/A 
(91 - 180 days)                                   
Accounts Receivables   -    -    109    85    (109)   (85)   -100.0%
Over 180 days                                   

 

Typically, we provide up to 30 days credit terms for our customers.

 

Account receivables, net of allowance for expected credit losses decreased by S$36,633 (approximately US$28,760) from S$38,384 (approximately US$30,135) to S$1,751 (approximately US$1,375) as of April 30, 2025, to April 30, 2026, respectively. The turnover days is 55 days and 84 days as of April 30, 2026 and April 30, 2025, respectively. A decrease in accounts receivable and turnover days is as a result of managing receivables. Subsequent to April, 2026 only S$211 (approximately US$166), representing 12.1% of the outstanding balance.

 

Lease Liabilities

 

   As of April 30, 
   2026   2025   Variance     
   SGD   USD   SGD   USD   SGD   USD   % Change 
Current Liabilities                                   
Lease liabilities – current   62,416    49,003    109,142    85,687    (46,726)   (36,684)   (42.8)%
                                    
Non-current liabilities                                   
Lease liabilities – non-current   110,256    86,562    22,703    17,824    87,553   68,738   385.6%
                                    
Total lease liabilities   172,672    135,565    131,845    103,511    40,827   32,054   31.0%

 

Total lease liabilities comprise current lease liabilities and non-current lease liabilities.

 

The total borrowings of the Group increased by S$40,827 (approximately US$32,054) from S$131,845 (approximately US$103,511) to S$172,672 (approximately US$135,565) as of April 30, 2025, to April 30, 2026, respectively.

 

Leases represented two property lease agreements with lease terms of 3 years where one will end in 2028 and another will end in 2029.

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditure or capital resources that is material to investors.

 

12

 

 

Bank Loan Covenants

 

As of April 30, 2026, we have an outstanding bank loan of S$78,366 (approximately US$61,526) under our temporary bridging loan facility with Enterprise Singapore, which matures in July 2027 and bears interest at 4.75% per annum. This loan is secured by joint and several guarantees from former Chief Executive Officer Andrew Yeo Eng Sian and Executive Chairman Beh Hook Seng. The loan agreement does not contain financial covenants. As of April, 2026, we were in compliance with all applicable covenants under this facility.

 

Related Party Transactions

 

As discussed above, we have received significant financial support from our major shareholder, TongHuai SG Enterprise Pte. Ltd., in the form of loans, there is no outstanding as of April 30, 2026. These loans are interest-free, unsecured, and due on demand with no written agreement or commitment for future funding. The interest-free nature of these loans represents a benefit to the Company that would not be available in an arms-length transaction with an unrelated party. If these loans were called for repayment, we would likely be unable to satisfy such demand from our existing resources and would need to seek alternative financing, which may not be available on acceptable terms, or at all. Our dependence on this related party financing represents a material risk to our liquidity and ability to continue as a going concern.

 

5.C. Research and Development, Patent and Licenses, etc.

 

Please refer to “Item 4. Information on the Company - D. Property, Plant and Equipment - Intellectual Property.

 

5.D. Trend Information.

 

Known Trends and Uncertainties

 

The following trends and uncertainties are reasonably likely to have a material impact on our results of operations, financial condition, and liquidity:

 

Going Concern and Liquidity Risk. As discussed elsewhere in this report, there is substantial doubt about our ability to continue as a going concern. As of April 30, 2026, we had a cash balance of only S$762,234 (approximately US$598,430) and incurred negative cash flow from operations of S$10,902,972 (approximately US$8,559,925) during the year then ended. Our ability to continue as a going concern is dependent upon management’s ability to successfully execute on its capital raising strategy, continued support from major shareholders, and our ability to increase revenues and reduce operating expenses. There can be no assurance that these measures will be successful or that we will be able to obtain additional financing on acceptable terms, or at all. This uncertainty is reasonably likely to continue to have a material adverse effect on our financial condition, results of operations, and ability to pursue our business strategy.

 

Customer Concentration. For the year ended April 30, 2026, our top five customers accounted for 80.7% of our total revenue, with our largest customer accounting for 37.8% of total revenue. The loss of any one of these significant customers, or a substantial reduction in their purchases, could have a material adverse effect on our revenue and results of operations. We are actively seeking to diversify our customer base, but there can be no assurance that we will be successful in these efforts or that customer concentration will decrease.

 

Geographic Concentration. For the year ended April 30, 2026, approximately 86.0% of our revenue was derived from customers in Singapore. This geographic concentration exposes us to risks related to the Singapore economy, including changes in demand, currency fluctuations, and regulatory changes specific to that market. While we are pursuing expansion into Southeast Asia and South Asia, there can be no assurance that we will be successful in these efforts.

 

Workforce Reduction. As of April 30, 2026, our workforce consisted of 10 full-time employees, a reduction from 25 employees as of April 30, 2025. While this restructuring has contributed to a reduction in our monthly operating cash burn, there can be no assurance that we will be able to maintain this reduced cost structure while pursuing our growth objectives, or that the reduction in workforce will not adversely impact our ability to execute on our business strategy, maintain product quality, or serve our customers.

 

13

 

 

5.E. Critical Accounting Policies and Estimates

 

We prepared our consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The preparation of these financial statements requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and the related disclosures. When reviewing our financial statements, you should consider our selection of critical accounting policies, the judgments and uncertainties affecting the application of those policies, and the sensitivity of our reported results to changes in conditions and assumptions.

 

We consider an accounting policy to be critical if it requires a choice between acceptable accounting methods or requires significant judgment in its application. We consider an accounting estimate to be critical if (i) the nature of the estimate or assumption is material because it requires a significant level of subjectivity and judgment, and (ii) the impact of the estimate or assumption is material to our financial condition and results of operations. We believe that the accounting policy relating to revenue recognition, and the accounting estimates relating to the allowance for slow-moving inventories, the allowance for expected credit losses on accounts receivable, and fair value measurement, involve the most significant judgments and estimates used in the preparation of our consolidated financial statements. These critical accounting policies and estimates should be read together with Note 2 to our consolidated financial statements included elsewhere in this annual report.

 

Actual results may differ from these estimates under different assumptions or conditions.

 

The significant accounting policies which we believe are the most critical to aid in fully understanding and evaluating our reported financial results are described below. Refer to “Note 2 - Summary of significant accounting policies” to the consolidated financial statements included elsewhere in this 20-F for more detailed information regarding our critical accounting policies.

 

Revenue recognition

 

The Company follows the revenue requirements of Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“Accounting Standards Codification (“ASC”) 606”). The core principle underlying the revenue recognition of this ASC allows the Company to recognize revenue that represents the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expect to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer.

 

To achieve that core principle, the Company applies the five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation.

 

Revenues are generally recognized upon the transfer of control of promised products or services provided to our customers, reflecting the amount of consideration we expect to receive for those products or services.

 

We currently generate our revenues from the following main sources:

 

Sales of microscopes and parts

 

The Company sells microscopes and parts. Revenue is recognized when the goods are delivered to the customer and all criteria for acceptance have been satisfied. The goods are often sold with a right of return.

 

14

 

 

The amount of revenue recognized is based on the transaction price, which comprises the contractual price. Based on the Company’s experience with similar types of contracts, variable consideration is typically constrained and is included in the transaction only to the extent that it is a highly probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.

 

At the end of each reporting date, the Company updates its assessment of the estimated transaction price, including its assessment of whether an estimate of variable consideration is constrained. The corresponding amounts are adjusted against revenue in the period in which the transaction price changes. The Company also updates its measurement of the asset for the right to recover returned goods for changes in its expectations about returned goods.

 

The Company has elected to apply the practical expedient to recognize the incremental costs of obtaining a contract as an expense when incurred where the amortization period of the asset that would otherwise be recognized is one year or less.

 

Service revenue

 

The Company provides microscopy-related services to customers. Revenue is recognized when the services are performed and the customer obtains the benefits from such services. For services performed over a period of time, revenue is recognized over the service period based on the Company’s progress toward satisfying the relevant performance obligation. For services performed at a specific point in time, revenue is recognized upon completion and customer acceptance of the services, where applicable.

 

The amount of revenue recognized is based on the transaction price, which generally comprises the contractual service fee. Based on the Company’s experience with similar contracts, variable consideration, if any, is included in the transaction price only to the extent that it is probable that a significant reversal of cumulative revenue recognized will not occur when the related uncertainty is subsequently resolved.

 

The Company has elected to apply the practical expedient to recognize incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that otherwise would have been recognized is one year or less.

 

Income taxes

 

The Company accounts for income taxes under FASB ASC 740. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets are also provided for net operating loss carry forwards that can be utilized to offset future taxable income.

 

Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period including the enactment date. A valuation allowance is established, when necessary, to reduce net deferred tax assets to the amount expected to be realized. Current income taxes are provided for in accordance with the laws of the relevant taxing authorities.

 

The provisions of FASB ASC 740-10-25, “Accounting for Uncertainty in Income Taxes,” prescribe a more-likely-than-not threshold for consolidated financial statement recognition and measurement of a tax position taken (or expected to be taken) in a tax return. This interpretation also provides guidance on the recognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, and related disclosures.

 

The Company did not accrue any liability, interest or penalties related to uncertain tax positions in its provision for income taxes for the years ended April 30, 2025 and 2026. The Company does not expect that its assessment regarding unrecognized tax positions will materially change over the next 12 months.

 

Critical accounting estimates

 

The discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. These principles require us to make certain estimates and judgments that affect the amounts reported in our consolidated financial statements.

 

The useful life and impairment of long-lived assets

 

The judgment that the long-lived assets, which include property and equipment, are being amortized over their useful lives and are not impaired are significant accounting estimates. We have estimated the useful life and residual value and concluded that no impairment loss was recognized as of April 30, 2025 and 2026.

 

Collectability of account receivables

 

We maintain an allowance for estimated credit losses inherent in its accounts receivable portfolio. In establishing the required allowance, management considers historical losses adjusted to take into account current market conditions and the Company’s customers’ financial condition, the receivable amount in dispute, and the current receivables aging and current payment patterns, over the contractual life of the receivable. The Company writes off the receivable when it is determined to be uncollectible.

 

Collectability of note receivables

 

We keep a close observation on the collection of note receivables to maintain an allowance for estimated credit losses inherent in the note receivables portfolio. To establish the required allowance, management considers historical losses, taking into account current market conditions and the borrower’s financial conditions to calculate the loss given default and probability of default for estimates on credit losses. The company writes off the receivable when it is deemed to be uncollectable.

 

Determination of the incremental borrowing rate for lease liabilities

 

We cannot readily determine the interest rate implicit in its lease arrangements and therefore uses its incremental borrowing rate to measure its lease liabilities. The incremental borrowing rate represents the rate we would have to pay to borrow, on a collateralized basis and over a similar term, an amount equal to the lease payments in a similar economic environment.

 

We determine its incremental borrowing rate using the prevailing interest rate on its current bank loan as the principal reference point, as management considers this rate to reflect our current credit risk and borrowing profile.

 

Recoverability of deferred tax assets

 

Our potential deferred tax assets relate primarily to tax losses and deductible temporary differences arising from its operations in Singapore. Management assesses the recoverability of these tax benefits at each reporting date by considering all available positive and negative evidence, including the historical and cumulative losses of the Singapore operations, recent operating results, forecasts of future taxable income, the expected reversal of taxable temporary differences, applicable Singapore tax regulations and available tax-planning strategies.

 

The assessment requires significant judgment, particularly in estimating whether sufficient taxable income will be generated in Singapore to utilize the tax losses and deductible temporary differences. Based on our cumulative loss position and the uncertainty surrounding the timing and amount of future taxable income in Singapore, management concluded that the applicable recognition criteria had not been met as of the reporting date. Accordingly, no deferred tax asset was recognized in the consolidated financial statements. Management will reassess the recoverability of these tax benefits at each reporting date, and any subsequent recognition would result in an income tax benefit in the period in which the assessment changes.

 

15

 

 

Item 15. Controls and Procedures

 

  (a) Disclosure Controls and Procedures.

 

Our management, with the participation of our interim Chief Executive Officer and Chief Financial Officer, has performed an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report, as required by Rule 13a-15(b) under the Exchange Act.

 

Our management evaluated the effectiveness of our disclosure controls and procedures as of April 30, 2026. Based on this evaluation, management concluded that the company’s disclosure controls and procedures were not effective due to material weaknesses arising from: (i) insufficient personnel with appropriate U.S. GAAP and SEC reporting experience; and (ii) the absence of formal accounting policies and procedures supporting U.S. GAAP and SEC reporting.

 

To remediate these weaknesses, the company have engaged, or plan to engage, external consultants, recruit qualified accounting personnel, formalize the accounting policies and controls, provide ongoing U.S. GAAP and SEC reporting training, and strengthen audit committee oversight.

 

As of the date of this report, the company has initiated the remediation plan and is in the process of implementing the identified measures. Specifically, the company has begun recruiting additional qualified accounting personnel with U.S. GAAP and SEC reporting experience and has conducted targeted training programs for existing staff. In addition, the company is developing performance evaluation and incentive mechanisms to further strengthen internal control awareness and accountability.

 

  (b) Management’s annual report on internal control over financial reporting.

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act. Our management evaluated the effectiveness of our internal control over financial reporting, as required by Rule 13a-15(c) of the Exchange Act, based on criteria established in the framework in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, our management has concluded that our internal control over financial reporting was not effective as of April 30, 2026, due to (i) a lack of sufficient skilled staff with U.S. GAAP knowledge and the SEC reporting knowledge for the purpose of financial reporting; and (ii) a lack of formal accounting policies and procedures manual to facilitate proper financial reporting in accordance with U.S. GAAP and SEC reporting requirements. The Company is in the process of engaging external consultants, recruiting qualified accounting personnel, formalizing the accounting policies and controls, providing ongoing U.S. GAAP and SEC reporting training, and strengthening audit committee oversight to remediate its internal controls.

 

  (c) Attestation report of the registered public accounting firm.

 

This Report does not include an attestation report by our independent registered public accounting firm. For as long as we are an “emerging growth company” under the JOBS Act, our independent registered public accounting firm will not be required to attest to the effectiveness of our internal controls over financial reporting pursuant to Section 404.

 

  (d) Changes in internal control over financial reporting.

 

There have been no changes in our internal controls over financial reporting occurred during the fiscal year ended April 30, 2026, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

16

 

 

PART III

 

Item 17. Financial Statements

 

See “Item 18. Financial Statements.”

 

Item 18. Financial Statements

 

Our consolidated financial statements are included at the end of this annual report, beginning with page F-1.

 

Item 19. Exhibits

 

Exhibit No.   Description of Exhibit
12.1*   Certification of Chief Executive Officer Required by Rule 13a-14(a)
     
12.2*   Certification of Chief Financial Officer Required by Rule 13a-14(a)
     
13.1**   Certification of Chief Executive Officer Required by Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code
     
13.2**   Certification of Chief Financial Officer Required by Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code
     
15.2*   Consent of Assentsure PAC, Independent Registered Public Accounting Firm
     
101.INS   Inline XBRL Instance Document
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document.
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

* Filed with this annual report on Form 20-F

**

Furnished herewith

 

17

 

 

SIGNATURES

 

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.

 

  Phaos Technology Holdings (Cayman) Limited
     
  By: /s/ Gan Hong Loon
  Name:  Gan Hong Loon
  Title: Interim Chief Executive Officer and Executive Director

 

Date: November 18, 2026

 

18

 

 

Phaos Technology Holdings (Cayman) Limited

 

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

    PAGES
Report of Independent Registered Public Accounting Firm PCAOB ID Number 6651   F-2
Report of Independent Registered Public Accounting Firm PCAOB ID Number 6783   F-3
Consolidated Balance Sheets as of April 30, 2025 and 2026   F-4
Consolidated Statements of Operations and Comprehensive Income for the Years Ended April 30, 2024, 2025 and 2026   F-5
Consolidated Statements of Change in Shareholders’ Equity for the Years Ended April 30, 2024, 2025 and 2026   F-6
Consolidated Statements of Cash Flows for the Years Ended April 30, 2024, 2025 and 2026   F-7
Notes to Consolidated Financial Statements   F-8

 

F-1

 

 

Report of Independent Registered Public Accounting Firm

 

Board of Directors and Shareholders

Phaos Technology Holdings (Cayman) Limited

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Phaos Technology Holdings (Cayman) Limited as of April 30, 2025 and 2024, and the related consolidated statements of operations and comprehensive loss, change in shareholders’ deficit, and cash flows for each of the two years in the period ended April 30, 2025, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of Phaos Technology Holdings (Cayman) Limited as of April 30, 2025 and 2024, and the results of its operations and its cash flows for each of the two years in the period ended April 30, 2025, in conformity with accounting principles generally accepted in the United States of America.

 

Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has incurred recurring losses from operations and has an accumulated deficit that raises substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These financial statements are the responsibility of the entity’s management. Our responsibility is to express an opinion on these financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to Phaos Technology Holdings (Cayman) Limited in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Phaos Technology Holdings (Cayman) Limited is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

/s/ Kreit & Chiu CPA LLP

 

We have served as Phaos Technology Holdings (Cayman) Limited’s auditor since 2023.

 

Los Angeles, California

 

September 18, 2025

 

F-2

 

 

Report of Independent Registered Public Accounting Firm

 

 

To the shareholders and the board of directors of Phaos Technology Holdings (Cayman) Ltd.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheet of Phaos Technology Holdings (Cayman) Ltd. (the “Company”) as of April 30, 2026, the related consolidated statements of operations and comprehensive income, changes in equity, and cash flows for the year ended April 30, 2026, and the related notes (collectively referred to as the “Financial Statements”). In our opinion, the financial statements present fairly, in all material respects, the consolidated financial position of the Company as of April 30, 2026, and the consolidated results of its operations and its cash flows for the year ended April 30, 2026, in conformity with accounting principles generally accepted in the United States of America (“US GAAP”).

 

Substantial Doubt about the Company’s Ability to Continue as a Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has incurred recurring losses from operations and has an accumulated deficit that raises substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (the “PCAOB”) and are required to be independent with respect to the Company in accordance with the United States federal securities laws. and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

/s/ Assentsure PAC

We have served as the Company’s auditor since 2026.

Singapore

August 31, 2026

PCAOB ID Number 6783 

 

F-3

 

 

PHAOS TECHNOLOGY HOLDINGS (CAYMAN) LIMITED

CONSOLIDATED BALANCE SHEETS

 

         US$ 
   As of April 30, 
   2025   2026   2026 
   S$   S$   US$ 
ASSETS               
Current assets               
Cash and cash equivalents   129,552    762,234    598,430 
Accounts receivable, net   38,384    1,751    1,375 
Inventories, net   310,007    543,712    426,868 
Loan to third party, net   400,000    -    - 
Deferred offering costs   497,302    -    - 
Other current assets   140,400    5,057,780    3,970,863 
Total current assets   1,515,645    6,365,477    4,997,536 
                
Non-current assets               
Property and equipment, net   286,558    139,273    109,343 
Right-of-use assets   131,845    172,672    135,565 
Total non-current assets   418,403    311,945    244,908 
                
TOTAL ASSETS   1,934,048    6,677,422    5,242,444 
                
LIABILITIES               
Current liabilities               
Accounts payable   93,931    298,826    234,608 
Accruals and other payables   541,678    573,875    450,549 
Amount due to major shareholders   2,995,423    -    - 
Borrowings   -    200,000    157,020 
Bank loans, current   55,613    58,313    45,782 
Operating lease liabilities, current   109,142    62,416    49,003 
Contract liabilities   -    53,279    41,829 
Total current liabilities   3,795,787    1,246,709    978,791 
                
Non-current liabilities               
Bank loans, non-current   78,366    20,053    15,744 
Operating lease liabilities, non-current   22,703    110,256    86,562 
Total non-current liabilities   101,069    130,309    102,306 
                
TOTAL LIABILITIES   3,896,856    1,377,018    1,081,097 
                
COMMITMENTS AND CONTINGENCIES   -     -     -  
                
SHAREHOLDERS’ (DEFICIT) / EQUITY               
Ordinary shares, Class A, USD 0.0001 par value and 16,446,750 outstanding at April 30, 2026; Ordinary shares, Class A, USD 0.0001 par value and 10,601,750 outstanding at April 30, 2025   1,445    2,194    1,723 
Ordinary shares, Class B, USD 0.0001 par value and 15,125,251 shares outstanding at April 30, 2026; Ordinary shares, Class B, USD 0.0001 par value and 15,125,251 shares outstanding at April 30, 2025   2,063    2,063    1,620 
                
Additional paid-in capital   10,239,208    23,569,613    18,504,502 
Subscription receivable   (37,251)   (37,251)   (29,246)
Accumulated other comprehensive (loss)/gain   (1,143)   88,694    69,634 
Accumulated deficit   (12,167,130)   (18,324,909)   (14,386,886)
Total shareholders’ (deficit) / equity   (1,962,808)    5,300,404    4,161,347 
                
TOTAL LIABILITIES AND EQUITY   1,934,048    6,677,422    5,242,444 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-4

 

 

PHAOS TECHNOLOGY HOLDINGS (CAYMAN) LIMITED

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

 

                  
   For the years ended April 30, 
   2024   2025   2026   2026 
   S$   S$   S$   US$ 
Revenue   1,882,803    167,707    132,077    103,694 
Cost of Goods sold (excluding depreciation shown separately below)   (985,099)   (130,641)   (114,767)   (90,104)
Employee benefits expenses   (1,851,971)   (2,462,326)   (2,739,571)   (2,150,836)
Depreciation expenses   (176,713)   (186,963)   (160,846)   (126,281)
Operating lease expense   (136,781)   (142,670)   (119,823)   (94,074)
Research and Development Expenses   (90,566)   (139,720)   -    - 
Other operating expenses   (1,144,802)   (1,161,663)   (3,319,747)   (2,606,334)
Impairment of loan to third parties   -    (1,223,608)   106,116    83,312 
Loss from operations   (2,503,129)   (5,279,884)   (6,216,561)   (4,880,623)
                     
Non-operating income:                    
Other income   186,828    151,283    67,949    53,347 
Interest expense   (43,543)   (8,463)   (9,167)   (7,198)
Total non-operating income, net   143,285    142,820    58,782    46,149 
                     
Loss before income taxes   (2,359,844)   (5,137,064)   (6,157,779)   (4,834,474)
Income tax expense   -    -    -   -
Net loss   (2,359,844)   (5,137,064)   (6,157,779)   (4,834,474)
                     
Other comprehensive income:                    
Foreign currency translation adjustment, net of income tax   -    (1,143)   89,837    70,531 
Total comprehensive loss   (2,359,844)   (5,138,207)   (6,067,942)   (4,763,943)
                     
Weighted average number of outstanding ordinary shares*                    
Basic and diluted   9,075,989    10,537,688    12,610,917    12,610,917 
                     
Net loss per share attributable to ordinary shareholders**                    
Basic and diluted   (0.26)   (0.49)   (0.49)   (0.38)

 

*   Give retroactive effect to reflect the reorganization on November 2024. See Note 1.
**   Basic and diluted net loss per share has been calculated based on the weighted-average number of Class A ordinary shares outstanding during the respective reporting periods. We have evaluated its net loss per share presentation in light of its dual-class capital structure, and the accounting policy applied is described in Note 2, “Summary of Significant Accounting Policies.”

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-5

 

 

PHAOS TECHNOLOGY HOLDINGS (CAYMAN) LIMITED

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

 

  

Shares

Outstanding

                  
   Ordinary shares   Additional   

Issued

shares,

            
  

Shares

Outstanding

  

Par

value

  

paid-in

capital

   

Amount

outstanding

     

Accumulated

losses

   Total 
       S$   S$    S$      S$   S$ 
Balance as of April 30, 2023   19,912,375    2,654    1,650,415     -   -    (4,670,222)   (3,017,153)
Net loss   -    -    -     -       (2,359,844)   (2,359,844)
Proceeds from Investors   -    -    -     8,296,364   -    -    8,296,364 
Shares issued during the year   5,686,501    837    8,333,615     (8,333,615)  -    -    837 
                                   
Balance as of April 30, 2024   25,598,876    3,491    9,984,030     (37,251)  -    (7,030,066)   2,920,204 
                                   
         US$    US$     US$       US$    US$ 
Balance as of April 30, 2024   25,598,876    2,560    7,322,288     (27,320)  -    (5,155,849)   2,141,679 

 

   Shares Outstanding*                   
   Ordinary shares (Class A and Class B) 
   Shares Outstanding*  

Par

value**

   Additional paid-in capital   Subscription Receivables   Accumulated other comprehensive loss   Accumulated deficit  

Total

shareholders’

(deficit)/

equity

 
       S$   S$   S$   S$   S$   S$ 
Balance as of April 30, 2024   25,598,876    3,491    9,984,030    (37,251)   -    (7,030,066)   2,920,204 
Net loss   -                        (5,137,064)   (5,137,064)
Translation loss                       (1,143)        (1,143)
Shares issued during the year   128,125    17    255,178    -    -     -    255,195 
                                    
Balance as of April 30, 2025   25,727,001    3,508    10,239,208    (37,251)   (1,143)   (12,167,130)   (1,962,808)
                                    
       US$   US$   US$   US$   US$   US$ 
Balance as of April 30, 2025   25,727,001    2,687    7,843,234    (28,534)   (876)   (9,320,022)   (1,503,511)

 

   Shares Outstanding*                   
   Ordinary shares (Class A and Class B) 
   Shares Outstanding*  

Par

value**

  

Additional

paid-in

capital

   Subscription Receivables   Accumulated other comprehensive loss   Accumulated deficit  

Total

shareholders’

(deficit)/

equity

 
       S$   S$   S$   S$   S$   S$ 
Balance as of April 30, 2025   25,727,001    3,508    10,239,208    (37,251)   (1,143)   (12,167,130)   (1,962,808)
Net loss   -                        (6,157,779)   (6,157,779)
Translation loss                       89,837         89,837 
Shares issued during the year   5,845,000    749    13,330,405    -         -    13,331,154 
                                    
Issuance of warrant   -     -     -^    -     -     -     -  
Balance as of April 30, 2026   31,572,001    4,257    23,569,613    (37,251)   88,694    (18,324,909)   5,300,404 
                                    
       US$   US$   US$   US$   US$   US$ 
Balance as of April 30, 2026   31,572,001    3,343    18,504,502    (29,246)   69,634    (14,386,886)   4,161,347 

 

^Warrant Movement within Additional paid-in capital

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-6

 

 

PHAOS TECHNOLOGY HOLDINGS (CAYMAN) LIMITED
CONSOLIDATED STATEMENTS OF CASH FLOWS

 

            2026 
   For the years ended April 30, 
   2024   2025   2026   2026 
   S$   S$   S$   US$ 
CASH FLOWS FROM OPERATING ACTIVITIES:                    
Net loss   (2,359,844)   (5,137,064)   (6,157,779)   (4,834,474)
Adjustments to reconcile net loss to net cash (used in) operating activities:                    
Allowance for/(Reversal of) allowance for expected credit losses on loan receivables   -    1,223,608    (106,116)   (83,312)
Provision for inventory obsolescence   -    -    

2,597

    

2,039

 
Property and equipment written off   16,929    -    25,972     20,391  
Gain on disposal of property and equipment           

(1,814

)   

(1,424

)
Depreciation   176,713    186,963    160,846    126,281 
Operating lease expenses   136,781    142,670    119,823    94,074 
Change in operating assets and liabilities:                    
Account receivables   135,614    374,205    36,633    28,761 
Contract assets   18,827    -    -    - 
Other current assets   71,491    (75,244)   (4,917,380)   (3,860,635)
Inventories   (36,061)   (122,423)   (236,302)   (185,521)
Account payables   202,814    (199,977)   204,895    160,863 
Accruals and other payables   198,001    96,556    32,197    25,278 
Contract liabilities   (33,951)   -    53,279    41,829 
Operating lease obligations   (136,781)   (142,670)   (119,823)   (94,074)
                     
Net cash used in operating activities   (1,609,467)   (3,653,376)   (10,902,972)   (8,559,924)
                     
CASH FLOWS FROM INVESTING ACTIVITIES:                    

Purchase of property and equipment  

   (121,318)   (240,212)   (39,719)   (31,183)

Proceeds from disposal of property and equipment

   -    -    2,000    1,570 
Loan to third party   (1,530,982)   (153,306)   -    - 
Receipt from loan to third party   -    60,680    506,116    397,352 
                     
Net cash (used in)/provided by investing activities   (1,652,300)   (332,838)   468,397    367,739 
                     
CASH FLOWS FROM FINANCING ACTIVITIES:                    
Proceeds from borrowings   -    -    200,000    157,020 
Repayment of bank loans   (143,483)   (440,455)   (55,613)   (43,662)
Proceeds from share issuance, net   8,117,201    255,195    13,828,456    10,856,721 
Loan from major shareholder   636,127    2,600,000    760,000    596,676 
Repayment to major shareholder   (2,865,374)   (337,330)   (3,755,423)   (2,948,383)
Deferred offering cost   (224,694)   (272,608)   -    - 
                     
Net cash provided by financing activities   5,519,777    1,804,802    10,977,420    8,618,372 
                     
Translation (loss)/gain   -    (1,143)   89,837    70,531 
                     
Net change in cash and cash equivalents   2,258,010    (2,182,555)   632,682    496,718 
                     
Cash and cash equivalents - beginning of year   54,097    2,312,107    129,552    101,712 
                     
Cash and cash equivalents - end of year   2,312,107    129,552    762,234    598,430 
                     
SUPPLEMENTAL CASH FLOW INFORMATION:                    
Cash paid for tax   -    -    -    - 
Cash paid for interest   43,543    8,463    9,167    7,198 
New shares issued with consideration receivable   37,251    37,251    -    - 

 

The accompanying notes form an integral part of these consolidated financial statements.

 

F-7

 

 

PHAOS TECHNOLOGY HOLDINGS (CAYMAN) LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

1 Organization and business overview

 

Phaos Technology Holdings (Cayman) Limited or the Company is an investment holding company incorporated on March 7, 2024 under the laws of the Cayman Islands. The Company, through its subsidiaries provides research and development, as well as the manufacturing and commercialization of advanced optical related technologies and products. Using its patented microsphere technology, the Company can significantly increase the magnification of existing traditional optical microscope by up to 4 times compared to its competitors, thereby allowing the Company’s client to see beyond the optical limit of 200nm in a cost effective manner. Currently, it is the only commercially available advanced optical microscope that can see below the 200nm optical limit with a commercially viable working distance.

 

In addition to selling optical and microscopy equipment, the Company develops software solution that is complementary to the hardware equipment in order to provide partners and clients with a fully integrated hardware and software microscopy solution. The software is augmented by algorithms around Artificial Intelligence to allow for use cases in pathology and metrology, whereby partners and clients can use the software to further analyze what they see through the hardware equipment.

 

The Company and its subsidiaries are collectively referred to as the “Company”. The Company is headquartered in Singapore.

 

On November 29, 2024, the Company proceeded with an internal reorganization whereby Phaos Technology Private Limited (PTPL) became our indirect wholly-owned subsidiary through a share swap. Subject to completion of the restructuring, both the ordinary and preferential shares of PTPL were swapped on a 1:125 basis to Phaos Technology Holdings (BVI) Limited. Subsequently, the shares of Phaos Technology Holdings (BVI) Limited were swapped 1:1 to Phaos Technology Holdings (Cayman) Limited, where the holders of the ordinary shares of PTPL eventually being swapped to Class A Ordinary Shares, and the holders of preferential shares of PTPL being swapped to Class B Ordinary Shares.

 

The Reorganization has been accounted for as a recapitalization among entities under common control since the same controlling shareholders controlled all these entities before and after the Reorganization. The consolidation of the Company and its subsidiaries has been accounted for at historical cost and prepared on the basis as if the aforementioned transactions had become effective as of the beginning of the first period presented in the accompanying consolidated financial statements. Results of operations for the periods presented comprise those of the previously separate entities combined from the beginning of the period to the end of the period eliminating the effects of intra-entity transactions.

 

The consolidated financial statements of the Company include the following entities:

 

 

Name 

Date of

incorporation

 

Percentage of

direct or

indirect interests

 

Place of

incorporation

  Principal activities
Phaos Technology Holdings (Cayman) Limited  March 7, 2024  Parent Company  Cayman Island  Investment holding
Phaos Technology Holdings (BVI) Limited  March 7, 2024  Parent Company  British Virgin Islands  Investment holding
Phaos Technology Pte. Ltd.  February 22, 2017  100%  Singapore  Research and development and commercialization of advanced microscopy-related solutions, technologies and products.
Phaos Solutions Vietnam Co., Ltd  February 7, 2025  100%  Vietnam  Research and development and commercialization of advanced microscopy-related solutions, technologies and products.

 

F-8

 

 

2 Summary of significant accounting policies

 

Basis of presentation

 

This summary of significant accounting policies is presented to assist in understanding the Company’s consolidated financial statements and have been consistently applied in the preparation of the financial statements. The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”).

 

Consolidation

 

The accompanying consolidated financial statements include the accounts of the Company, its wholly owned subsidiaries. All   inter-company balances, investment and capital, if any, have been eliminated upon consolidation.

 

The Company entered into a loan arrangement with PT Neura. Management evaluated its involvement with PT Neura in accordance with ASC 810, Consolidation, and determined that PT Neura is a variable interest entity (“VIE”) because it did not have sufficient equity at risk to finance its activities without additional subordinated financial support.

 

Management further concluded that the Company is not the primary beneficiary of PT Neura. Although the Company holds a variable interest through its loan receivable, it does not have the current power to direct the activities that most significantly affect PT Neura’s economic performance. The Company does not have board representation, management appointment rights, or other governance rights beyond customary creditor protections under the loan agreement. Although the loan agreement provides the Company with a contingent right to convert the outstanding loan into a controlling equity interest upon specified events of default, the conversion right is not currently exercisable and therefore does not provide the Company with current decision-making power.

 

The Company’s economic interest is limited to its rights as a lender under the loan agreement. The Company is not entitled to participate in PT Neura’s residual returns, does not have an obligation to absorb losses beyond the carrying amount of its loan receivable, and has no contractual obligation to provide additional financial support or guarantee PT Neura’s obligations. Accordingly, management concluded that the Company does not possess both the power to direct the activities that most significantly affect PT Neura’s economic performance and the obligation to absorb losses or the right to receive benefits that could potentially be significant to PT Neura. Therefore, the Company is not the primary beneficiary of PT Neura, and PT Neura is not consolidated in the Company’s consolidated financial statements.

 

The loan has been fully written off as at April 30, 2026.

 

Use of estimates

 

The preparation of consolidated financial statements in conformity with US GAAP requires management to make judgements, estimates and assumptions that affect the application of policies and reported amounts of assets, liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making the judgements about carrying values of assets and liabilities that are not readily apparent from other sources. Significant accounting estimates reflected in the Company’s consolidated financial statements include, but are not limited to the useful lives and impairment of long-lived assets, and collectability of accounts receivable and other current assets.   Actual results may differ from these estimates.

  

Determination of the incremental borrowing rate for lease liabilities

 

The company cannot readily determine the interest rate implicit in its lease arrangements and therefore uses its incremental borrowing rate to measure its lease liabilities. The incremental borrowing rate represents the rate the company would have to pay to borrow, on a collateralized basis and over a similar term, an amount equal to the lease payments in a similar economic environment.

 

The company determine its incremental borrowing rate using the prevailing interest rate on its current bank loan as the principal reference point, as management considers this rate to reflect our current credit risk and borrowing profile.

 

Recoverability of deferred tax assets

 

The company potential deferred tax assets relate primarily to tax losses and deductible temporary differences arising from its operations in Singapore. Management assesses the recoverability of these tax benefits at each reporting date by considering all available positive and negative evidence, including the historical and cumulative losses of the Singapore operations, recent operating results, forecasts of future taxable income, the expected reversal of taxable temporary differences, applicable Singapore tax regulations and available tax-planning strategies.

 

The assessment requires significant judgment, particularly in estimating whether sufficient taxable income will be generated in Singapore to utilize the tax losses and deductible temporary differences. Based on the company’s cumulative loss position and the uncertainty surrounding the timing and amount of future taxable income in Singapore, management concluded that the applicable recognition criteria had not been met as of the reporting date. Accordingly, no deferred tax asset was recognized in the consolidated financial statements. Management will reassess the recoverability of these tax benefits at each reporting date, and any subsequent recognition would result in an income tax benefit in the period in which the assessment changes.

 

F-9

 

 

Valuation of Underwriter’s Warrant

 

The company used the Black-Scholes option pricing model to estimate the fair value of the Underwriter’s Warrant issued in connection with the company’s initial public offering. The valuation required management to make significant estimates and assumptions, including expected volatility, expected term, risk-free interest rate and dividend yield. Expected volatility was determined based on the historical volatility of selected comparable publicly traded companies due to the company’s limited trading history. Changes in these assumptions could materially impact the estimated fair value of the warrant.

 

Cash and cash equivalents

 

Cash and cash equivalents primarily consist of bank deposits with original maturities of three months or less, which are unrestricted as to withdrawal and use.

 

Accounts receivable, net

 

Accounts receivable mainly represent amounts due from customers that meet the revenue recognition criteria. These accounts receivables are recorded net of any allowance for credit losses and specific customer credit allowances. The Company maintains an allowance for estimated credit losses inherent in its accounts receivable portfolio. In establishing the required allowance, management considers historical losses adjusted to take into account current market conditions and the Company’s customers’ financial condition, the receivable amount in dispute, and the current receivables aging and current payment patterns, over the contractual life of the receivable. The Company writes off the receivable when it is determined to be uncollectible.

 

Other current assets

 

Other current assets primarily consists of deposits, prepayments made to vendors or services providers for future services that have not been provided, and other receivables from third parties. These advances are reviewed periodically to determine whether their carrying value has become impaired. As of April 30, 2024, management believes that the Company’s other current assets are not impaired. As of April 30, 2025, there was an impairment to loan to third party of S$1,223,608 (US$960,655). As of April 30, 2026, the loan to third parties has been written off.

 

Inventories

 

Inventories are measured at the lower of cost or net realizable value. The cost of inventories is based on the first-in, first-out principle. Due to the minimal amount of inventory, the Company does not operate a batch program that aggregates the number of units of similar inventory.

 

The cost of inventories include expenditure incurred in acquiring the inventories and other costs incurred in bringing them to their existing location and condition. General and administrative costs are not charged to inventory as they are not considered direct costs towards production.

 

The Company does not mortgage, pledge or subject any inventory to lien. Inventories by the Company is not collateralized in any form.

 

Deferred offering costs

 

Pursuant to ASC 340-10-S99-1, offering costs directly attributable to an offering of equity securities are deferred and would be charged against the gross proceeds of the offering as a reduction of additional paid-in capital. These costs include legal fees related to the registration drafting and counsel, consulting fees related to the registration preparation, the SEC filing and print related costs. As of April 30, 2025, the Company had not concluded its IPO hence professional fees are recorded as deferred offering costs. As of April 30, 2025, the accumulated deferred offering cost was S$497,302 (US$390,432). As of April 30, 2026, the accumulated deferred offering costs have been reclassed to Additional Paid-in Capital.  

 

Property and equipment, net

 

Property and equipment are stated at cost less accumulated depreciation and impairment if applicable. The Company computes depreciation using the straight-line method over the estimated useful lives of the assets as follows:

 

Property and equipment   lesser of lease term or expected useful life
Computers   3 years
Furniture and fittings   5 years
Office and production equipment   3 to 5 years
Renovation   3 years

 

F-10

 

 

2 Summary of significant accounting policies (cont’d)

 

The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the consolidated statement of income. Expenditures for maintenance and repairs are charged to expense as incurred, while additions renewals and betterments, which are expected to extend the useful life of assets, are capitalized. The Company also re-evaluates the periods of depreciation to determine whether subsequent events and circumstances warrant revised estimates of useful lives.

 

Impairment of long-lived assets

 

The Company evaluates the recoverability of its long-lived assets (asset groups), including property and equipment and operating lease right-of-use assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of its asset (asset group) may not be fully recoverable. When these events occur, the Company measures impairment by comparing the carrying amount of the assets to the estimated undiscounted future cash flows expected to result from the use of the asset (asset group) and their eventual disposition. If the sum of the expected undiscounted cash flows is less than the carrying amount of the asset (asset group), the Company recognizes an impairment loss based on the excess of the carrying amount of the asset (asset group) over their fair value. Fair value is generally determined by discounting the cash flows expected to be generated by the asset (asset group), when the market prices are not readily available. The adjusted carrying amount of the asset is the new cost basis and is depreciated over the asset’s remaining useful life. Long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. For the years ended April 30, 2025 and 2026, no impairment of long-lived assets was observed and recognized.

 

Fair value measurements

 

ASC 820 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in pricing the asset or liability. ASC 820 establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

 

  Level 1 - observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
  Level 2 - other inputs that are directly or indirectly observable in the marketplace.
  Level 3 - unobservable inputs which are supported by little or no market activity.

 

The carrying amounts of cash and cash equivalents, accounts receivable, other current assets, inventories and liabilities, accounts payable, and accruals and other payables approximate their fair values because of their generally short maturities.

 

Revenue recognition

 

The Company follows the revenue requirements of Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“Accounting Standards Codification (“ASC”) 606”). The core principle underlying the revenue recognition of this ASC allows the Company to recognize revenue that represents the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expect to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer.

 

To achieve that core principle, the Company applies five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation.

 

Revenues are generally recognized upon the transfer of control via acceptance of promised products provided to our customers, reflecting the amount of consideration we expect to receive for those products or services.

 

F-11

 

 

2 Summary of significant accounting policies (cont’d)

 

The Company generates revenue from the following streams:

 

Sales of microscopes and parts

 

The Company sells microscopes and parts. Revenue is recognized when the goods are delivered to the customer and all criteria for acceptance have been satisfied. The goods are often sold with a right of return when goods are defective. Up till April 30, 2026, there has been no returns from customers.

 

The amount of revenue recognized is based on the transaction price, which comprises the contractual price. Based on the Company’s experience with similar types of contracts, variable consideration is typically constrained and is included in the transaction only to the extent that it is a highly probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.

 

The Company has elected to apply the practical expedient to recognize the incremental costs of obtaining a contract as an expense when incurred where the amortization period of the asset that would otherwise be recognized is one year or less.

 

Service revenue

 

The Company provides microscopy-related services to customers. Revenue is recognized when the services are performed and the customer obtains the benefits from such services. For services performed over a period of time, revenue is recognized over the service period based on the Company’s progress toward satisfying the relevant performance obligation. For services performed at a specific point in time, revenue is recognized upon completion and customer acceptance of the services, where applicable.

 

The amount of revenue recognized is based on the transaction price, which generally comprises the contractual service fee. Based on the Company’s experience with similar contracts, variable consideration, if any, is included in the transaction price only to the extent that it is probable that a significant reversal of cumulative revenue recognized will not occur when the related uncertainty is subsequently resolved.

 

The Company has elected to apply the practical expedient to recognize incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that otherwise would have been recognized is one year or less.

 

Contract Assets and contract liabilities

 

The contract assets primarily relate to the Company’s rights to bill for work completed but not billed at the reporting date. The contract assets are transferred to receivables until the subsequent billing phase. The contract liabilities primarily relate to advance billing to customers based on the contract, for which project task has not yet been completed.

 

Segments

 

ASC 280, “Segment Reporting”, establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organizational structure as well as information about geographical areas, business segments and major clients in financial statements for detailing the Company’s business segments. Based on the criteria established by ASC 280, the Company’s chief operating decision maker (“CODM”) has been identified as the Chief Executive Officer, who reviews consolidated results when making decisions about allocating resources and assessing performance of the Company. As a whole and hence, the Company has only one reportable segment. The Company does not distinguish between markets or segments for the purpose of internal reporting.

 

Concentrations and credit risk

 

The Company maintains cash with banks in Singapore (“SGN”). Should any bank holding cash become insolvent, or if the Company is otherwise unable to withdraw funds, the Company would lose the cash with that bank; however, the Company has not experienced any losses in such accounts and believes it is not exposed to any significant risks on its cash in bank accounts. In Singapore, a depositor has up to S$100,000 insured by Singapore Deposit Insurance Corporation (“SDIC”).

 

Financial instruments that potentially expose the Company to the concentration of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company has designed their credit policies with an objective to minimize their exposure to credit risk. The Company’s accounts receivable are short term in nature and the associated risk is minimal. The Company conducts credit evaluations on its clients and generally does not require collateral or other security. The Company periodically evaluates the creditworthiness of the existing clients in determining the allowance for doubtful accounts primarily based upon the age of the receivables and factors surrounding the credit risk of specific clients.

 

As of April 30, 2025 and 2026, the Company’s assets were located in Singapore and the Company’s revenue was derived from the operation in Singapore, Philippines and Indonesia.

 

For the financial years ended April 30, 2025 and 2026, top 5 customers accounted for 85% and 81% of total revenue, respectively. The top 5 suppliers accounted for 85% and 95% of our total purchases, respectively.

 

For the financial year ended April 30, 2025, customer A, customer B, customer C, customer D and customer E accounted for 23%, 21%, 18%, 13% and 10% of the Company’s total revenue and customer A, customer D and customer E accounted for 13%, 30% and 46% of the total accounts receivable as of April 30, 2025; whereas customer B and customer C have no outstanding as of April 30, 2025. For the financial year ended April 30, 2026, customer A, customer B, customer C, customer D and customer E accounted for 38%, 12%, 11%, 11% and 9% of the Company’s total revenue and customer A and customer C accounted for 29% and 40% of the total accounts receivable as of April 30, 2026; whereas customer B, customer D and customer E have no outstanding as of April 30, 2026.

 

For the financial year ended April 30, 2025, vendor A, vendor B, vendor C, vendor D and vendor E accounted for 30%, 28%, 18%, 6% and 3% of the Company’s total purchases and vendor A, vendor B and vendor E accounted for 34%, 57% and 8% of the total accounts payable as of April 30, 2025; whereas vendors C and D have no outstanding as of April 30, 2025. For the financial year ended April 30, 2026, vendor A, vendor B, vendor C, vendor D and vendor E accounted for 81%, 5%, 4%, 3% and 2% of the Company’s total purchases and vendor A and vendor B accounted for 73%, and 0.1% of the total accounts payable as of April 30, 2026; whereas vendors C, D and E have no outstanding as of April 30, 2026.

  

Government grants

 

Government grants are recognized when there is reasonable assurance that the grant will be received, and all attaching conditions will be complied with. Government grant is recognized as ‘Other income’ in Consolidated statement of operations and comprehensive loss.

 

F-12

 

 

2 Summary of significant accounting policies (cont’d)

 

Commitments and contingencies

 

In the normal course of business, the Company is subject to contingencies, including legal proceedings and claims arising out of the business that relate to a wide range of matters, such as government investigations and tax matters. The Company recognizes a liability for such contingency if it determines it is probable that a loss has occurred and a reasonable estimate of the loss can be made. The Company may consider many factors in making these assessments including historical and the specific facts and circumstances of each matter.

 

Employee benefits

 

Employee benefits are recognized as an expense, unless the cost qualifies to be capitalized as an asset.

 

  i) Defined contribution plans

 

Defined contribution plans are post-employment benefit plans under which the Company pays fixed contributions into separate entities such as the Central Provident Fund on a mandatory, contractual or voluntary basis. The Company has no further payment obligations once the contributions have been paid. Contributions to defined contribution pension schemes are recognized as an expense in the period in which the related service is performed.

 

  ii) Short-term compensated absences

 

Employee entitlements to annual leave are recognized when they accrue to employees. A provision is made for the estimated liability for annual leave as a result of services rendered by employees up to the balance sheet date.

 

Related parties

 

Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Parties are also considered to be related if they are subject to common control or significant influence of the same party, such as a family member or relative, shareholder, or a related corporation.

 

The Company follows ASC 850 Related Party Disclosures for the identification of related parties and disclosure of related party transactions.

 

Foreign currency and foreign currency translation

 

The accompanying consolidated financial statements are presented in Singapore Dollars (“S$”), which is the reporting currency of the Company. The functional currency of the Company and its subsidiary in the British Virgin Island is United States Dollar (“US$”).

 

Convenience translation

 

Translations of the consolidated balance sheet, consolidated statement of operations and comprehensive loss, statement of shareholders deficit and consolidated statement of cash flows from S$ into US$ as of and for the year ended April 30, 2026 are solely for the convenience of the reader and were calculated at the rate of US$0.7851 = S$1 as set forth in the statistical release of the Federal Reserve System on April 30, 2026. No representation is made that the SGD amounts could have been, or could be, converted, realized or settled into US$ at that rate on April 30, 2026, or at any other rate., or at any other rate.

 

Income taxes

 

The Company accounts for income taxes under FASB ASC 740. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets are also provided for net operating loss carry forward that can be utilized to offset future taxable income.

 

Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period including the enactment date. A valuation allowance is established, when necessary, to reduce net deferred tax assets to the amount expected to be realized. Current income taxes are provided for in accordance with the laws of the relevant taxing authorities.

 

The provisions of FASB ASC 740-10-25, “Accounting for Uncertainty in Income Taxes,” prescribe a more-likely-than-not threshold for consolidated financial statement recognition and measurement of a tax position taken (or expected to be taken) in a tax return. This interpretation also provides guidance on the recognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, and related disclosures.

 

The Company did not accrue any liability, interest or penalties related to uncertain tax positions in its provision for income taxes for the years ended April 30, 2025 and 2026. The Company does not expect that its assessment regarding unrecognized tax positions will materially change over the next 12 months.

 

F-13

 

 

2 Summary of significant accounting policies (cont’d)

 

Leases

 

The Company is a lessee of non-cancellable operating leases for its corporate office premises. The Company determines if an arrangement is a lease at inception. Lease assets and liabilities are recognized at the present value of the future lease payments at the lease commencement date. The interest rate used to determine the present value of the future lease payments is the Company’s incremental borrowing rate based on the information available at the lease commencement date. The Company generally uses the base, non-cancellable lease term in calculating the right-of-use assets and liabilities.

 

The Company has elected not to recognize right-of-use assets and lease liabilities for leases that, at the commencement date, have a lease term of 12 months or less and do not contain a purchase option that the Company is reasonably certain to exercise. Lease payments associated with qualifying short-term leases are recognized as lease expense on a straight-line basis over the lease term.

 

The Company evaluates the impairment of its right-of-use assets consistent with the approach applied for its other long-lived assets. The assessment of possible impairment is based on its ability to recover the carrying value of the asset from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected to include the carrying amount of finance and operating lease liabilities in any tested asset group and include the associated lease payments in the undiscounted future pre-tax cash flows. For the years ended April 30, 2025 and 2026, the Company did not have any impairment loss against its operating lease right-of-use assets.

 

The Company’s operating lease liabilities and right-of-use assets are disclosed in Note 8.

 

Net earnings / (loss) per share

 

Basic earnings (loss) per share is computed by dividing net earnings (loss) attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the year. Diluted earnings per share reflect the potential dilution that could occur if outstanding stock options, warrants and convertible debt were exercised or converted into ordinary shares. When the Company incurs a loss, diluted shares are not included, as their inclusion would have an anti-dilutive effect. The Company did not have any dilutive securities or debt for each of the years ended April 30, 2025 and 2026.

 

The Company has two classes of ordinary shares outstanding: Class A Ordinary Shares and Class B Ordinary Shares. Holders of Class A Ordinary Shares are entitled to receive dividends when and if declared and distributions upon liquidation. Holders of Class B Ordinary Shares are not entitled to receive dividends or participate in distributions and, accordingly, the Company considers the Class B Ordinary Shares to be non-participating in nature.

 

The Company evaluates the presentation of earnings (loss) per share in accordance with ASC 260, Earnings Per Share, taking into consideration the rights and characteristics of each class of ordinary shares, therefore EPS is only calculated for Class A Ordinary Shares as it’s participative in nature and EPS for Class B Ordinary Shares was nil.

 

For the periods presented, the Company incurred net losses and no dividends or distributions were declared or paid. The Company will continue to evaluate the presentation of earnings (loss) per share in future reporting periods based on the rights and characteristics of each class of ordinary shares and the applicable guidance in ASC 260.

 

Going Concern

 

The accompanying audited consolidated financial statements have been prepared assuming the Company will continue as a going concern. As of the year ending April 30, 2026, the Group had a net loss of S$6,157,779 (approximately US$4,834,474) and incurred a negative cashflow from operations of S$10,902,972 (approximately US$8,559,924), against a cash balance of S$762,234 (approximately US$598,430).   This raises substantial doubt about our ability as a going concern.

 

To sustain its ability to support the Company’s operating activities, the Company considered supplementing its sources of funding through the following:

 

  - Cash flow from operations through sale of our products
  - Continuous support from major shareholders, such as TongHuai SG Enterprise Pte. Ltd. which has provided for the shareholders’ loan

 

Management has commenced a strategy to raise debt and equity. However, there can be no certainty that these additional financings will be available on acceptable terms or at all. If management is unable to execute this plan, there will likely be a material adverse effect on the Company’s business. All these factors raise substantial doubt about the ability of the Company to continue as a going concern.

 

There is no immediate liquidation concern for the Company; however, there is substantial doubt on the Company being a going concern but the management has positive mitigation plan to handle going concern issue.

 

The audited consolidated financial statements do not include any adjustments that might be necessary if the Group is unable to continue as a going concern.

 

Recent Accounting Pronouncements

 

The Company is an “emerging growth company” (“EGC”) as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, EGC can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. The Company made the election to delay the adoption of new or revised accounting standards.

 

In July 2025, the FASB issued ASU 2025-05—Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides a practical expedient for estimating expected credit losses on current accounts receivable and current contract assets arising from transactions accounted for under ASC 606. Under the practical expedient, an entity may assume that current economic conditions as of the balance sheet date will remain unchanged for the remaining life of the applicable asset when developing its reasonable and supportable forecast. The amendments are effective for the Company for annual reporting periods beginning after December 15, 2025, including interim periods within those annual periods. Early adoption is permitted, and the amendments are required to be applied prospectively. The Company is currently evaluating whether to elect the practical expedient and does not expect adoption to have a material effect on its consolidated financial statements.

 

In December 2025, the FASB issued ASU 2025-10—Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities, which establishes guidance for the recognition, measurement, presentation and disclosure of government grants received by business entities. Under the amendments, a government grant is recognized when it is probable that the entity will comply with the conditions attached to the grant and that the grant will be received. Grants related to income are recognized in earnings on a systematic and rational basis over the periods in which the related costs are recognized, while grants related to assets may be accounted for using either a cost-accumulation or deferred-income approach. The amendments are effective for the Company for annual reporting periods beginning after December 15, 2028, including interim periods within those annual periods. Early adoption is permitted. As the Company receives or may receive government grants, it is currently evaluating the impact of adopting this guidance on its accounting policies, presentation and related disclosures.

 

Except as mentioned above, the Group does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the Company’s consolidated balance sheets, statements of operations and cash flows.

 

F-14

 

 

3 Accounts receivable, net

   2025   2026   2026 
   As of April 30, 
   2025   2026   2026 
   S$   S$   US$ 
Accounts receivable   38,384    1,751    1,375 
Less: allowance for credit losses   -    -    - 
Total accounts receivable   38,384    1,751    1,375 

 

Movement of allowance for credit losses are as follows:

 

   2025   2026   2026 
   As of April 30, 
   2025   2026   2026 
   S$   S$   US$ 
Allowance for credit losses, beginning balance   23,607    -    - 
Addition   19,217    -    - 
Write off   (42,824)   -   -
Allowance for credit losses, ending balance   -    -    - 

 

 

4 Other current assets

   2025   2026   2026 
   As of April 30, 
   2025   2026   2026 
   S$   S$   US$ 
Deposits   48,108    30,804    24,184 
Prepayments   44,042    4,965,662    3,898,541 
Other current assets   48,250    61,314    48,138 
Total other current assets   140,400    5,057,780    3,970,863 

 

Prepayments comprise prepaid insurance premiums and advance payments for business development services.

 

Prepayments increased from S$44,042 as of April 30, 2025 to S$4,965,662 (US$3,898,541) as of April 30, 2026. The increase was primarily attributable to the prepayments made in relation to the business development services engaged for the (i) advisory services relating to introduction of potential targets for mergers and acquisitions for synergies and expansion of business streams of S$2,477,406 (US$1,945,011), (ii) fees prepaid for services involving introductions to business partners, joint venture partners in order to expand our businesses of S$2,172,166 (US$1,705,368) and (iii) insurance premiums of S$290,687 (US$228,218) for liability insurance for the Company’s Directors and Officers. These prepayments are relating to upfront retainers for services to be delivered over future periods, ranging from a period of 7 – 19 months.

 

These prepayments support the Company’s efforts to expand its business network, gain access to potential sources of funding and identify acquisition and collaboration opportunities. These activities align with the business activities described on page 37 and are intended to support revenue growth and improve profitability. There can be no assurance that these services will result in funding, completed transactions or improved financial performance.

 

The Company has considered its liquidity constraints when deciding to make these prepayments. Although the payments reduced cash available for current operations, the Company considered access to funding and acquisition and collaboration opportunities important to the Company’s sustainability. The Company therefore prioritized securing these services based on expected benefits derived.

 

None of these prepayment transactions involved related parties.

 

5 Loan to third party

   2025   2026   2026 
   As of April 30, 
   2025   2026   2026 
   S$   S$   US$ 
Loan to third party   1,623,608    -    - 
Allowance for credit losses   (1,223,608)   -    - 
Loan to third parties, net   400,000    -    - 

 

On 19th January 2024, the Company provided a loan to PT Neura Integrasi Solusi, a technology company providing pathology related software solutions. The loan bears an interest at a rate of 1% per annum, with a maturity date of 36 months and is due on demand. The purpose of the loan was to provide working capital for our Indonesian partner in the expansion of our business. For the year ending April 30, 2025, the Company loaned a total of S$153,306 (US$120,360) to PT Neura Integrasi Solusi while repayment made by PT Neura Integrasi Solusi was S$60,680 (US$47,640), giving rise to a balance of S$1,623,608 (US$1,274,695) as at April 30, 2025.

 

The carrying amount of the loan as of April 30, 2025 has been partially impaired by S$1,223,608 (US$960,655), with S$400,000 (US$314,040) as the carrying amount after impairment. As of August 2025, the Company has reached an agreement with PT Neura Integrasi Solusi where the first repayment of approximately S$400,000 will happen in September 2025. The borrower of the loan, PT Neura Integrasi Solusi is neither affiliated with the Company nor the shareholders of the Company.

 

For the financial year ended April 30, 2026, the company received repayments of S$502,283, resulting in a reversal of impairment of S$102,283 recorded as reversal of allowance for expected credit loss of loan receivable. As of April 30, 2026, the Company does not expect further repayments and thus has fully written off the loan to PT Neura Integrasi Solusi.

 

6 Borrowings

 

   As of April 30, 
   2025   2026   2026 
   S$   S$   US$ 
Loan from third party   -    200,000    157,020 

 

On March 4, 2026, the company entered into a loan agreement for S$200,000 unsecured fixed rate which expires in September 2026. The loan which carries interest of 2.0% per month is guarantee by Tay Beng Boon.

 

As of April 30, 2026 the company paid interest of S$4,000 (approximately US$3,140). 

 

F-15

 

 

7 Property and equipment, net

   2025   2026   2026 
   As of April 30, 
   2025   2026   2026 
   S$   S$   US$ 
Production Equipment   742,860    645,918    507,110 
Computer and Software   94,238    82,674    64,907 
Furniture and Fittings   9,070    6,444    5,059 
Office Equipment   6,689    4,709    3,697 
Renovation   117,803    25,000    19,628 
Construction in Progress   868    -    - 
Total   971,528    764,745    600,401 
Less: accumulated depreciation   (684,970)   (625,472)   (491,058)
Net book value   286,558    139,273    109,343 

 

Depreciation expense for the years ended April 30, 2025 and 2026 was S$186,963 and S$160,846 (US$126,281), respectively.

 

8 Inventories, net

 

   2025   2026   2026 
   As of April 30, 
   2025   2026   2026 
   S$   S$   US$ 
             
Parts   53,021    19,184    15,061 
Partial finished goods   94,391    127,515    100,112 
Finished goods   162,595    399,610    313,734 
Inventories   310,007    546,309    428,907 

Less: Provision of stock obsolescence

   

-

    

(2,597

)   

(2,039

)

Inventories, net

   

310,007

    

543,712

    

426,868

 

 

Movement in provision of stock obsolescence:

 

   2025   2026   2026 
   As of April 30, 
   2025   2026   2026 
   S$   S$   US$ 
             
Beginning of the year   -    -    - 
Charge for the year   -    2,597    2,039 
End of the year   -    2,597    2,039 

 

During the year ended April 30, 2026, inventories recognized as cost of goods sold amounted to S$2,796 (approximately US$2,195). The Company reviews inventories for excess, obsolescence and slow-moving items based on inventory aging, historical and forecast demand, expected future usage and estimated net realizable value. As a result of this assessment, the Company recognized an inventory write-down of S$2,597 (approximately US$2,039) for slow-moving and obsolete inventories within cost of goods sold for the year ended April 30, 2026.

 

9 Leases

 

The Company determines if a contract contains a lease at inception. US GAAP requires that the Company’s leases be evaluated and classified as operating or finance leases for financial reporting purposes. The classification evaluation begins at the commencement date and the lease term used in the evaluation includes the non-cancellable period for which the Company has the right to use the underlying asset, together with renewal option periods when the exercise of the renewal option is reasonably certain and failure to exercise such option which results in an economic penalty.

 

The Company has two office premises operating lease agreements with lease terms of three years. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. Upon adoption of ASU 2016-02, no right-of-use (“ROU”) assets nor lease liability was recorded for the lease with a lease term of one year.

 

F-16

 

 

9 Leases (cont’d)

 

As of April 30, 2026, the Company had the following non-cancellable operating lease contracts:

 

Description of lease  Lease term
    
Office premises  3 years

 

  (a) Amount recognized in the consolidated balance sheets:

 

   2025   2026   2026 
   As of April 30, 
   2025   2026   2026 
   S$   S$   US$ 
             
Right-of-use assets   131,845    172,672    135,565 
Operating lease liabilities               
Current   109,142    62,416    49,003 
Non-current   22,703    110,256    86,562 
Total operating lease liabilities   131,845    172,672    135,565 

 

  (b) A summary of lease cost recognized in the Group’s consolidated statements of operations is as follows:

 

   2024   2025   2026   2026 
   Years Ended April 30, 
   2024   2025   2026   2026 
   S$   S$   S$   US$ 
                     
Operating lease expense   136,781    142,670    119,823    94,074 

 

Lease Commitment

 

Future minimum lease payments under non-cancellable operating lease agreements as of April 30, 2026 were as follows:

 

   Minimum lease payment 
   S$   US$ 
Years ending April 30,          
2027   68,548    53,817 
2028   68,548    53,817 
2029   45,866    36,010 
Total future minimum lease payments   182,962    143,644 
Less imputed interest   (10,290)   (8,079)
Present value of operating lease liabilities   172,672    135,565 
Less: current portion   (62,416)   (49,003)
Long-term portion   110,256    86,562 

 

The following summarizes other supplemental information about the Company’s lease as of April 30:

 

   As of April 30, 
   2025   2026 
Weighted average discount rate   4.75%   4.25%
Weighted average remaining lease term   13 months    33 months 

 

F-17

 

 

10 Bank loans

 

On August 11, 2022, the Company has acquired a 5-year S$270,000 temporary bridging loan which expires in July 2027. The bank loan which carries interest of 4.75% per annum is secured by joint and several guarantee by Andrew Yeo Eng Sian (previous Chief Executive Officer) and Beh Hook Seng (Chairman) at no consideration to the company. As of April 30, 2025 and 2026, the carrying amount of the bank loan was S$133,979 and S$78,366 (US$  61,526), respectively.

 

On November 1, 2022, the Company has acquired another 5-year S$500,000 secured fixed rate bank loan which expires in November 2027. The bank loan which carries interest of 7.75% per annum is secured by joint and several guarantee by Beh Hook Seng, Andrew Yeo Eng Sian, Wong Teck Far and Chua Jun Hao, David. As of April 30, 2025, the bank loan has been fully paid.

 

Interest expenses for the years ended April 30, 2025 and 2026 are S$8,463 and S$5,167 (US$4,057), respectively.

 

The maturities schedule is as follows:

 

   Amount   Amount 
   S$   US$ 
Year ending April 30,          
2027   58,313    45,782 
2028   20,053    15,744 
Total   78,366    61,526 
Less: current portion   (58,313)   (45,782)
Long-term portion   20,053    15,744 

 

11 Accruals and other current liabilities

 

   2025   2026   2026 
   As of April 30, 
   2025   2026   2026 
   S$   S$   US$ 
             
Accruals   99,429    216,884    170,276 
Provision for reinstatement   32,000    30,000    23,553 
Other payables   51,421    15,617    12,261 
Non-trade creditors   358,828    311,374    244,459 
Total   541,678    573,875    450,549 

 

12 Equity

 

Ordinary shares

 

The Company was incorporated under the laws of the Cayman Islands on March 7, 2024. The original authorized share capital of the Company was US$100,000 divided into 950,000,000 Class A Ordinary Shares and 50,000,000 Class B Ordinary Shares, par value US$0.0001 per share. Holders of Class A Ordinary Shares and Class B Ordinary Shares have the same rights except for voting rights. Each holder of our Class A Ordinary Share is entitled to one (1) vote per share. Each holder of our Class B Ordinary Share is entitled to twenty (20) votes per share.

 

The Company issued 25,598,876 Class A and Class B Ordinary Shares as of April 30, 2024 and 25,727,001 Class A and Class B Ordinary Shares as of April 30, 2025, where the Company received S$255,195 (US$193,000) from investors for the issuance of 128,125 shares for the year ended April 30, 2025.

 

The Company issued 31,572,001 Class A and Class B Ordinary shares as of April 30, 2026.

 

Post restructuring, for April 30, 2024, the Company had received a total of S$8,297,201 (US$6,514,133) in share application monies, and S$37,251 (US$29,246) in monies to be received from investors, in relation to the planned issuance of 5,686,501 shares at an average issue price of S$1.46 per share.

 

The Company has completed the restructuring process on November 29, 2024.

  

Underwriter’s warrant

 

In connection with the Company’s initial public offering consummated on November 14, 2025, the company issued an underwriter’s warrant (the “Underwriter’s warrant”) to Network 1 Financial Securities, Inc pursuant to the underwriting agreement dated November 12, 2025.

 

The Underwriter’s warrant entitles the holder to purchase up to 232,875 Class A ordinary shares of the Company at an exercise price of US$5.00 per share, subject to customary anti-dilution adjustments. The warrant becomes exercisable on November 13, 2025 and expires on November 12, 2030.

 

The warrant includes a cashless exercise feature and contains customary provisions related to stock splits, stock dividends, recapitalizations and similar events.

 

The Company evaluated the warrant under ASC 815-40, “Derivatives and Hedging – Contracts in Entity’s Own Equity” and concluded that the warrant qualifies for equity classifications because:

 

-the warrant is indexed to the Company’s own stock;
-the warrant provides for physical or net share settlement
-the exercise price and number of shares are fixed; and
-the warrant does not contain provisions that could require cash settlement

 

Accordingly, the warrant was classified as equity and recorded within additional paid-in capital. The Company determined the fair value of the Underwriter’s Warrant using the Black Scholes option pricing model. The fair value of the warrant at issuance was approximately US$3.22 and was recorded as an offering cost, resulting in a corresponding reduction to additional paid-in capital.

 

The following assumptions were used in the valuation of the Underwriter’s warrant at issuance:

 

Assumption   Amount
Share price   US$3.85
Exercise price   US$5.00
Expected volatility   126.8%
Risk-free interest rate   3.71%
Expected term   5.00 years
Dividend yield   0.0%

 

The fair value measurement of the warrant was classified as a Level 3 fair value measurement under ASC 820 due to the use of unobservable inputs.

 

The warrants were classified as equity and recorded within additional paid-in capital. Their fair value at issuance was recognized as an equity issuance cost associated with the IPO. As equity-classified instruments, the warrants are not subsequently remeasured.

 

F-18

 

 

13 Related party transactions and balances

 

The table below sets forth the major related parties and their relationships with the Company as of April 30, 2025 and 2026:

 

Name of related parties   Relationship with the Company
TongHuai SG Enterprise Pte. Ltd.   Major shareholder
Singlight Technology Holdings Pte. Ltd.   Shareholder of the Company

 

Amount due to major shareholder

 

The Company received loan proceeds from major shareholder, TongHuai SG Enterprise Pte. Ltd. for business working purposes. The payable balance due to TongHuai SG Enterprise Pte. Ltd. was S$2,995,423 and nil as of April 30, 2025 and 2026. In the year ended April 30, 2025 loan from TongHuai SG Enterprise Pte. Ltd. was S$2,600,000 (US$2,041,260) and repayment was S$337,330 (US$264,838). In the year ended April 30, 2026 loan from TongHuai SG Enterprise Pte. Ltd. was S$760,000 (US$596,676) and repayment was S$3,755,423 (US$2,948,383). Such balance is interest free, unsecured, and repayable on demand. Due to the in demand nature of the advance, the company reclassified the “Amount due to major shareholder” from non-current liabilities to current liabilities.

 

TongHuai SG Enterprise Pte. Ltd. will continue to provide cash injections to the Company based on agreement as and when signed.

 

14 Income taxes

 

Caymans and BVIs

 

The Company and its subsidiaries are domiciled in the Cayman Islands and British Virgin Islands. The locality currently enjoys permanent income tax holidays; accordingly, the Company does not accrue for income taxes.

 

Singapore

 

Phaos Technology Pte. Ltd. is incorporated in Singapore and are subject to Singapore Corporate Tax on the taxable income as reported in its statutory financial statements adjusted in accordance with relevant Singapore tax laws. The applicable tax rate is 17% in Singapore, with 75% of the first S$10,000 taxable income and 50% of the next S$190,000 taxable income exempted from income tax.

 

Vietnam

 

Phaos Solutions Vietnam Co., Ltd is incorporated in Vietnam and are subject to Vietnam Corporate Tax on the taxable income as reported in its statutory financial statements adjusted in accordance with relevant Vietnam tax laws. The applicable tax rate is 20% in Vietnam, but from October 1, 2025 onwards, applicable rate will be 15% if the annual turnover is no more than VND 3 billion.

 

A reconciliation between of the statutory tax rate to the effective tax rate are as follows:

 

   2025   2026   2026 
   Years Ended April 30, 
   2025   2026   2026 
   S$   S$   US$ 
             
Loss before tax   (5,137,064)   (6,157,779)   (4,834,474)
Singapore income tax rate   (17.0)%   (17.0)%   (17.0)%
Reconciling items:               
Non-deductible expenses   4.7%   0.2%   0.2%
Valuation allowance   12.3%   16.8%   16.8%
Effective tax rate   -    -    - 

 

F-19

 

 

14 Income taxes (cont’d)

 

Deferred tax

 

Significant components of deferred tax were as follows:

 

   2025   2026   2026 
   Years Ended April 30, 
   2025   2026   2026 
   S$   S$   US$ 
Net operating loss carried forward   10,094,281    15,493,651    12,164,065 
Deferred tax assets, gross   1,716,028    2,633,921    2,067,891 
Valuation allowance   (1,716,028)   (2,633,921)   (2,067,891)
Deferred tax assets, net of valuation allowance   -    -    - 

 

Deferred tax assets are recognized in the consolidated financial statements only to the extent that it is probable that future taxable income will be available against which the Company can utilize the benefits. The use of these tax losses is subject to the agreement of the tax authorities and compliance with certain provisions of the tax legislations of the respective countries in which the group companies operate.

 

The deferred tax assets not recognized as of April 30, 2025 and 2026 were S$1,716,028 and S$2,633,921 (US$2,067,891) respectively. The deferred tax assets not recognized was primarily related to the Company’s net loss (tax losses) carry forwards, in the judgment of management, are not more likely than not to be realized. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that all or some portion of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Tax losses on Net Operating Losses can be carried forward indefinitely unless there’s a major change in shareholding.

 

15 Other operating expenses

 

   Years Ended April 30, 
   2024   2025   2026   2026 
   S$   S$   S$   US$ 
Consumable expenses   86,532    -    -    - 
Marketing expenses   87,008    58,008    19,659    15,434 
Professional fees   691,464    620,014    1,143,052    897,410 
Travelling expenses   136,651    165,435    71,699    56,291 
Other expenses   143,147    318,206    2,085,337    1,637,199 
    1,144,802    1,161,663    3,319,747    2,606,334 

 

F-20

 

 

16 Other income

 

   Years Ended April 30, 
   2024   2025   2026   2026 
   S$   S$   S$   US$ 
Interest income   2    5,832    225    177 
Government grants   116,542    62,644    20,968    16,462 
Gain on disposal of property and equipment   -    -    1,814    1,424 
Other   70,284    82,807    44,942    35,284 
    186,828    151,283    67,949    53,347 

 

17 Loss per share

 

Basic loss per share is the amount of losses available to each ordinary share outstanding during the reporting period. Diluted loss per share is the amount of losses available to each ordinary share outstanding during the financial year April 30, 2026.

 

   2024   2025   2026   2026 
   Years Ended April 30, 
   2024   2025   2026   2026 
   S$   S$   S$   US$ 
Numerator:                
Net loss available to ordinary shareholders   (2,359,844)   (5,137,064)   (6,157,779)   (4,834,474)
Denominator:                    
Weighted average number of ordinary shares outstanding – basic and diluted   9,075,989    10,537,688    12,610,917    12,610,917 
Loss per ordinary share:                    
Basic and diluted   (0.26)   (0.49)   (0.49)   (0.38)

 

The Company has two classes of ordinary shares outstanding: Class A Ordinary Shares and Class B Ordinary Shares. Holders of Class A Ordinary Shares are entitled to receive dividends when and if declared and distributions upon liquidation. Holders of Class B Ordinary Shares are not entitled to receive dividends or participate in distributions and, accordingly, the Company considers the Class B Ordinary Shares to be non-participating in nature.

 

The Company evaluates the presentation of earnings (loss) per share in accordance with ASC 260, Earnings Per Share, taking into consideration the rights and characteristics of each class of ordinary shares, therefore EPS is only calculated for Class A Ordinary Shares as it’s participative in nature and EPS for Class B Ordinary Shares was nil.

 

For the periods presented, the Company incurred net losses and no dividends or distributions were declared or paid. The Company will continue to evaluate the presentation of earnings (loss) per share in future reporting periods based on the rights and characteristics of each class of ordinary shares and the applicable guidance in ASC 260.

 

18 Commitments and Contingencies

 

For the details on future minimum lease payment under the non-cancellable operating leases as of April 30, 2026, please refer to Note 9 set forth in the Notes to the Consolidated Financial Statements.

 

As of April 30, 2025 and 2026, the Company did not have any capital commitments and contingencies.

 

19 Subsequent events

 

The Company has assessed all subsequent events through the date that the consolidated financial statements were issued and other than the following, there are no further material subsequent events that require disclosure in these consolidated financial statements.

 

On August 11, 2026, the Company filed a registration statement on Form F-1/A with the U.S. Securities and Exchange Commission in connection with a proposed offering of Class A ordinary shares and warrants to purchase Class A ordinary shares. As of the date these consolidated financial statements were issued, the registration statement had not been declared effective, and the terms, timing and completion of the proposed offering remained subject to market conditions and other customary conditions. Accordingly, no adjustment relating to the proposed offering has been recognized in the consolidated financial statements.

 

On July 21, 2026, the Company issued a notice convening an extraordinary general meeting of shareholders to consider and vote upon proposals to (i) increase the Company’s authorized share capital and (ii) authorize the Board of Directors, in its discretion, to implement one or more share consolidations during the two-year period following the meeting, subject to a maximum cumulative consolidation ratio of 15-to-1. The meeting, originally scheduled for August 18, 2026, was subsequently postponed and rescheduled to August 31, 2026. As of the date these consolidated financial statements were issued, the proposals remained subject to shareholder approval and no share consolidation had been implemented. Accordingly, these matters were treated as non-recognized subsequent events and did not result in any adjustment to the consolidated financial statements for the year ended April 30, 2026.

 

F-21

 

Keep reading